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Investigation of Genomic Instability Induced by G-Quadruplexes in the
Absence of Functional Topoisomerase 1 in Yeast
Alexandra Noel Berroyer, B.S., M.S.
Advisory Professor: Nayun Kim, Ph.D.
Topoisomerase 1 (Top1) is an enzyme that removes transcriptionally generated
negative supercoils by binding and nicking DNA. Since transcription of guanine-rich DNA leads
to the formation of G-quadruplex (G4) structures, Top1’s function likely suppresses G4formation. In support of this, Top1 significantly reduces co-transcriptional G4 DNA-associated
genomic instability at a model G4-motif in Saccharomyces cerevisiae. However, whether Top1
suppresses G4-formation on a genome-wide scale in yeast remains unexplored. Therefore, I
aimed to uncover if deletion of Top1 enhances genome-wide G4-formation in S. cerevisiae.
As an approach to quantify global G4-formation, I expressed the G4-specific antibody BG4
from a yeast vector to perform chromatin immunoprecipitation next generation sequencing
(ChIP-seq) and immunofluorescence experiments. While the G4-antibody’s function was
verified in vitro, ChIP and immunofluorescence experiments failed, possibly due to
localization of BG4 to the cytoplasm rather than the nucleus of yeast cells. Thus, future
attempts at enumerating G4s in TOP1-deletion yeast cells should include the usage of
expressed BG4 fused to a nuclear localization signal sequence or purified BG4 protein.
Top1 mutants arise in cancer cells treated with the Top1-targeting anticancer drug
camptothecin (CPT). Here, I show that the impact on G4-induced recombination in yeast
depends on the type of CPT-resistant Top1 mutant expressed. While expression of a Top1
mutant defective in duplex DNA binding results in G4-recombination levels equivalent to cells
vi

completely lacking Top1, expression of cleavage-defective Top1 mutants has an even greater
impact on G4-mediated instability. I also find that Top1 cleavage-defective mutants bind G4s
in vitro and that the SPRTN homolog Wss1 involved in DNA/protein crosslink resolution partly
suppresses G4-induced recombination in yeast cells expressing Top1 cleavage-defective
mutants. Collectively, these data suggest that Top1 cleavage-defective mutants induce
instability at guanine-rich DNA through G4-stabilization in vivo. Further, I uncovered that
another G4-binding protein, Nsr1 or yeast nucleolin, contributes to G4-instability in yeast cells
expressing Top1 mutants and provide additional evidence indicating that Top1 cleavagedefective mutants and Nsr1 interact when bound to G4s to form a potential replication block.
Bioinformatic data revealed that cancer genomes harboring Top1 mutants predicted to be
functionally defective exhibit enriched mutagenesis at G4-motifs. Yeast genetic datum
showing that Top1 cleavage-defective mutants and Nsr1 have a synergistic effect on G4instability through cooperative G4-binding taken together with the result of bioinformatic
analyses suggest that CPT-resistance conferring Top1 mutants could induce mutagenesis at
G4-motifs in cancer cells and complicate patient treatment. Since loss of Top1 function
increases G4-instability, identifying additional protein factors that suppress or instigate G4mediated DNA damage in the absence of functional Top1 is an attractive future direction of
this work.
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Chapter 1: Introduction

Note: Portions of this chapter were derived from a previously published review in Genes.
BERROYER, A. & KIM, N. 2020. The functional consequences of eukaryotic topoisomerase 1
interaction with G-quadruplex DNA. Genes, 11(2), 1-15. Genes is an MDPI journal. For all
articles published in MDPI journals, copyright is retained by the authors. In addition, the article
may be reused and quoted provided that the original published version is cited:
https://www.mdpi.com/authors/rights.

Article

available

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073998/pdf/genes-11-00193.pdf.
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1.1 Introduction to non-B DNAs and G-Quadruplex (G4) Structures
DNA can assume alternative DNA structures in addition to the canonical doublehelical, B-form DNA (Wells, 2007; Mirkin, 2008; Zhao et al., 2010). Collectively termed “NonB DNAs”, these alternative structures form during transcription, replication, and DNA repair
when the duplex structure of B-form DNA is disrupted and strand separation occurs to foster
non-B DNA-formation. This is because DNA strand separation greatly increases the risk for
intra-strand base pairing or non-canonical base pairing to occur, which hold non-B DNA
structures together. Additionally, non-B DNA formation is associated with negative helical
stress as negatively supercoiled DNA can give rise to the formation of single-stranded DNA
patches (Napierala et al., 2005; Sun and Hurley, 2009; Irobalieva et al., 2015).
There are many types of non-B DNAs including hairpins, cruciform, triplexes, Z-DNA,
and R-loops. One of the most widely studied non-B DNAs is the G-quadruplex (G4) structure.
G4s form in guanine-rich DNA when planar guanine tetrads, held together by Hoogsteen
bonds among guanines, become stacked (Figure 1) (Burge et al., 2006). While non-canonical
G4-motifs do exist and are structure capable (Piazza et al., 2017; Jana et al., 2021), the
guanine-rich sequence of GGGN1-7GGGN1-7GGGN1-7GGG is widely accepted in the field as the
consensus, canonical G4-motif where N denotes the DNA bases between guanine triplets
extruding from the structure as loops (Figure 1). G4-formation is dynamic, and a wide variety
of G4 structure types have been documented. G4 DNAs can be either intermolecular where
they are made up of more than one DNA strand or intramolecular where guanines from only
a single DNA strand interact (Teng et al., 2021). Intramolecular G4s can adopt different
structural topologies depending on if the glycosidic bonds of tetrad associated guanosines
2

are in the syn- or anti-conformation. G4s containing guanosines all in the anti-conformation
have a “parallel” topology where all four DNA strands of the structure have the same
directionality (Figure 2A) (Burge et al., 2006; Teng et al., 2021). Conversely, G4s harboring a
mix of guanosines in anti- and syn-conformations give rise to “anti-parallel” or “hybrid” G4s
where the DNA strands holding the structure together are oriented in different directions
(Figure 2B-C) (Burge et al., 2006; Teng et al., 2021).
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Figure 1. G4s form in guanine-rich DNA when guanines interact. Guanines from G4-forming
sequences interact through Hoogsteen bonding to form planar guanine tetrads that stack
upon each other to form the higher order G4 structure. Monovalent cations, like K +, stabilize
G4s through electrostatic interactions. Gray squares shown in folded G4 DNA structure
represent guanine bases that comprise a tetrad.
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Figure 2. G4s adopt different conformations. Derived from TENG, F., JIANG, Z., GUO, M., TAN,
X, CHEN, F., XI, X., XU, Y. 2021. G-quadruplex DNA: a novel target for drug design. Cell. Mol.
Life Sci., 78, 6557–6583. https://doi.org/10.1007/s00018-021-03921-8. Gray squares
represent guanines in tetrads. Black line represents DNA in G4-forming sequence and arrows
denote directionality of the DNA strand. A. Parallel G4. B. Anti-parallel G4. C. Hybrid G4.
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G4s have been shown to form in the genomes of essentially all lifeforms ranging from
viruses and bacteria all the way to complex eukaryotes such as humans (Metifiot et al., 2014;
Hänsel-Hertsch et al., 2017; Yadav et al., 2021). The human genome contains greater than
700,000 loci that are G4-capable under conditions that promote G4-stabilization (Chambers
et al., 2015). A study investigating genome-wide in vivo G4-formation in cells found that G4s
form in nucleosome depleted regions undergoing active transcription (Hänsel-Hertsch et al.,
2016). The Saccharomyces cerevisiae genome contains ~1,400 G4-motifs (Todd et al., 2005).
While the exact number of stable G4s that form in the yeast genome remains to be
uncovered, genetic experiments suggest that as in human cells, G4-formation occurs during
active transcription in yeast (Kim and Jinks-Robertson, 2011).
The non-random genomic locations of G4s within the human and S. cerevisiae
genomes suggest that G4s are involved in certain DNA transactions. G4 DNAs occur in
repetitive DNA containing tandem guanines, such as guanine-rich micro- and minisatelletes
(Todd et al., 2005; Capra et al., 2010; Amrane et al., 2012; Ogloblina et al., 2015). G4s are also
associated with functional genetic elements including telomeres, ribosomal DNA, and
promoter regions (Todd et al., 2005; Capra et al., 2010). Multiple studies have demonstrated
the enrichment of G4 motifs at gene promoters suggesting that G4s play both activating and
inactivating roles in transcription (Kim, 2019). Some of G4 DNA’s roles in transcriptional
regulation are related to the modulation of chromatin remodeling (Varizhuk et al., 2019)
(Reina and Cavalieri, 2020). G4-motifs are present at meiotic and mitotic recombination
hotspots, suggesting they play a role in programmed recombination (Capra et al., 2010). More
recently, G4s have been shown to play a role in DNA repair, where experiments conducted in
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yeast revealed that G4-formation followed by G4-binding of the Zuo1 protein directs
nucleotide excision repair proteins to UV-induced DNA damage located near G4s (De Magis
et al., 2020).
While there is no question that G4s play positive, modulatory roles in cells, G4formation, if unregulated, can be extremely deleterious. Cells do have a repertoire of proteins
that can resolve G4s when they are no longer needed (Mendoza et al., 2016), but G4s still are
a source of genomic instability, especially when their formation or stability in cells is altered.
G4s have been shown to stall transcription and both leading and lagging strand replication
(Sarkies et al., 2010; Lopes et al., 2011; Sarkies et al., 2012; Schiavone et al., 2014; Dahan et
al., 2018; Kim, 2019). The stalling of transcription and replication machinery will lead to DNA
breaks if not correctly restarted (Gomez-Gonzalez and Aguilera, 2019). And the mutagenic
capacity of G4s extends to both large-scale and small-scale genomic variations. In terms of
large-scale genome changes, G4s are linked to translocations as well as the whole loss of
chromosome arms (Katapadi et al., 2012; Yadav et al., 2014; Bacolla et al., 2016). In terms of
small-scale genome changes, portions of the human genome harboring a high density of G4motifs have increased levels of nucleotide deletions, nucleotide insertions, and single
nucleotide polymorphisms (Williams et al., 2020).
Since G4s cause genomic instability when dysregulated, it is not surprising that
aberrant G4-formation is linked to disease. Bloom syndrome is a disease caused from
mutation of the gene encoding the BLM helicase (German, 1993), which is a potent G4unwinder (Sun et al., 1998). Bloom syndrome patients have a strong pre-disposition to
cancer, and a study by van Wietmarschen et al. showed that G4s contribute greatly to
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genomic instability in BLM-deficient cells (van Wietmarschen et al., 2018). This indicates that
aberrant G4-stability could contribute to the high rates of cancer development among Bloom
syndrome patients. Further linking G4s to cancer development, oncogenic breakpoints were
shown to occur at G4s (Nambiar et al., 2011; Nambiar et al., 2013; Williams et al., 2015). G4s
present at oncogenic translocation break points were shown to block progression of DNA
polymerases, suggesting that G4-replication conflicts could be a source of the DNA breaks
that promote formation of these harmful rearrangements (Williams et al., 2015). And studies
conducted with a G4-specific antibody showed that ~10,000 more G4s form in immortalized
keratinocytes than in primary keratinocytes, suggesting cancer cells have a higher propensity
for G4-formation and G4-induced genomic instability than healthy cells (Hänsel-Hertsch et
al., 2016). In addition to cancer, G4s are linked to neurodegenerative disorders. Amyotrophic
lateral sclerosis (ALS) and frontotemporal dementia (FTD), linked diseases marked by
degeneration and loss of neurons (Lomen-Hoerth et al., 2002; Umoh et al., 2018), are
commonly caused by expansion of the hexanucleotide repeat (HRE) GGGGCCn located in the
C9ORF72 gene (DeJesus-Hernandez et al., 2011; Renton et al., 2011). Because the C9orf72
HRE is G4-capable, it was proposed that G4s contribute to ALS-FTD pathogenesis by
promoting expansion of HRE (Fratta et al., 2012; Reddy et al., 2013; Haeusler et al., 2014).
Further, the binding of the protein nucleolin to the C9ORF72 G4 could stabilize the structure
and lead to development of ALS-FTD (Haeusler et al., 2014).
1.2 Introduction to Topoisomerase 1 (Top1)
Eukaryotic Topoisomerase I (Top1) is a type IB topoisomerase that binds to doublestranded DNA (dsDNA) and cleaves a single strand initially forming a phospho-tyrosyl bond at
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the 3’ end of the cleaved DNA. This intermediate is termed the Top1 cleavage complex. Selfcatalyzed ligation to the 5’ hydroxyl restores the intact double-stranded DNA. During Top1’s
catalytic cycle, helical torsional DNA stress in the form of positive or negative supercoils are
removed by the swiveling of DNA strands between the cleavage and ligation steps.
As mentioned above, the first step in the catalytic cycle of topoisomerase reaction is
binding to DNA. The X-ray structure of human Top1 bound to a DNA duplex shows that two
lobes clamp around B-form dsDNA throughout the catalytic cycle (Stewart et al., 1998;
Redinbo et al., 1998). Core domains I and II form the “cap” lobe while the core domains III, Cterminal domain, and the linker domain form the “catalytic” lobe. Although a 22-bp duplex
DNA was used for the structure determination, Top1 contacts only the central 10 bp of the
DNA from the position -4 to +6 (with the cleavage between the -1 and +1 positions). The
essential catalytic tyrosine residue (Y723 for human Top1) is covalently attached to the
phosphodiester bond 3’ of the -1 position nucleotide. When this residue is mutated to a noncatalytic phenylalanine, the aromatic ring is closely positioned facing the phosphodiester
bond between the -1 and +1 nucleotides. In total, 24 to 26 amino acids make direct contact
with the DNA molecule, but there is only one base-specific contact indicating that the Top1–
DNA interaction is not strongly sequence-dependent. Further experiments showed that,
rather than sequence, superhelicity of DNA determines the strength of Top1–DNA interaction
(Madden et al., 1995). Using the catalytically inactive mutant with phenylalanine at amino
acid 723, it was shown that human Top1 binds preferentially to the superhelical DNA and
particularly to the nodes created by the crossing of the two helical dsDNAs. In this
experiment, Top1 Y723F initially bound to a relaxed DNA molecule redistributed to bind
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added supercoiled DNA indicating the Top1–DNA interaction is dynamic and transient for
relaxed DNA. No preference for positively or negatively supercoiled DNA was found. Although
the core, the linker and the C-terminal domains participate in DNA binding, a truncated form
that contains only the linker and the core domain retained the preference for binding
supercoiled DNA. The linker domain was later determined to be important in the preferential
binding to supercoiled DNA (Yang et al., 2009). Vaccinia Top1 is an example of a
topoisomerase with a strict sequence requirement for binding; it binds and cleaves at 5’CCCTT-3’ (Sekiguchi and Shuman, 1994). For eukaryotic Topoisomerases, however, the
sequence requirement is less restricted. Inferring the sites of Top1 binding preference from
the sites of Top1 cleavage preference, the consensus for strong cleavage for rat and wheat
germ Top1 is 5’ A/T G/C T/A T (from the -4 to -1 position). However, a significant level of
cleavage occurs when the -1 position is a C residue (Been et al., 1984). When the Top1
cleavage sites are analyzed by trapping the cleavage complex with the Top1 poison
camptothecin (CPT), the sites of strong preference are clearly shifted from its preferential
cleavage site in the absence of the intercalating drug (Siu and Pommier, 2013).
Top1’s catalytic activity of removing positive and negative supercoils from DNA serves
to maintain genomic stability (Kim and Jinks-Robertson, 2017). Specifically, positive
supercoiled DNA is overwound while negatively supercoiled DNA is underwound. In the
absence of Top1, negative and positive supercoils accumulate in cells during transcription.
Top1 is recruited to genomic regions undergoing active transcription through interactions
with RNA polymerase 2 and chromatin remodeling proteins so that torsional stress can be
relieved (Phatnani et al., 2004; Baranello et al., 2016; Husain et al., 2016). Both positive and
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negative forms of transcriptionally generated helical stress are deleterious, thus their
removal by Top1 protects the genome (Ma and Wang, 2014; Ma and Wang, 2016; Kim and
Jinks-Robertson, 2017; Tubbs and Nussenzweig, 2017). Negatively supercoiled DNA is linked
to genomic instability as this loose DNA conformation renders DNA more prone to damage
and induces the formation of non-B DNA structures (Hamperl and Cimprich, 2014). Positively
supercoiled DNA can prevent DNA unwinding and causes genomic instability by blocking RNA
polymerase during transcription, which can lead to dsDNA breaks (Gomez-Gonzalez and
Aguilera, 2019). Further, our understanding of the function of Top1 has expanded beyond
maintaining torsional homeostasis in DNA to protect the genome. In 1997, Sekiguchi and
Shuman reported on the ribonuclease activity of vaccinia and human Top1 and suggested the
potential role of Top1 in processing RNA (Sekiguchi and Shuman, 1997). Later, the
endoribonuclease activity of eukaryotic Top1 was shown to be required in its role of removing
ribonucleotides incorporated into DNA (Kim et al., 2011; Williams et al., 2013; Cho et al.,
2013). In absence of a functional RNase H2 complex, which initiates error-free ribonucleotide
excision repair, Top1-mediated cleavage at single ribonucleotides embedded in a DNA strand
leads to mutations and genome instability (Cornelio et al., 2017; Huang et al., 2017). The role
of Top1 in transcriptional regulation was also recently highlighted. Along with the type II
topoisomerase Top2, Top1 functions to recruit RNA polymerase to the promoters of highly
transcribed genes (Sperling et al., 2011) and is required to maintain the superhelicity of
certain inducible promoters (Pedersen et al., 2012). More recently, the role of Top1 as a
component of the RNA polymerase complex and as a positive regulator of promoter escape
and transcription elongation was described (Baranello et al., 2016). In the following section
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of this dissertation another seminal function is discussed: the role of Top1 in reducing the
formation of genotoxic DNA secondary structures.
1.3 The Role of Top1 in Preventing the Formation of G4 DNA and Other Secondary
Structures
Non-canonical DNA structures can disrupt processes such as replication, transcription,
and DNA repair. An R-loop or the long extensive hybrid between RNA and DNA strands is one
such non-canonical nucleic acid structures that is a major source of endogenous genome
instability (Aguilera and Gaillard, 2014). Top1 function counteracts the formation of extensive
R-loops at highly transcribed regions. At the ribosomal DNA repeat loci in the yeast genome,
the loss of Top1 leads to disruption of transcription and accumulation of R-loops, both of
which are severely exacerbated in absence of the RNA:DNA hybrid processing nucleases
RNase H1 and H2 (El Hage et al., 2010; El Hage et al., 2014). R-loop accumulation in the
absence of Top1 function and the elevated genome instability as a consequence were also
observed in mammalian cells (Manzo et al., 2018). Apart from the RNA–DNA hybrid or Rloops, DNA can assume structures other than the Watson-Crick double helical, B DNA
structure (Mirkin, 2008). Duplex DNA, under the condition of increasing supercoils,
particularly negative torsional stress, undergoes structural transformation to partially singlestranded DNA (Irobalieva et al., 2015). The exposed bases in this context can lead to intrastrand interactions promoting secondary structure formation. For example, base-pairing
within a strand of DNA can occur at inverted repeats, forming a basis for a hairpin structure
or a cruciform DNA. CAG trinucleotide repeat-containing DNA strands are known to assume
stable hairpin structures through the intra-strand base pairing of Cs and Gs. Other unusual,
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non-B structure includes the triplex or H-DNA formed at purine-rich sequences such as GAA
trinucleotide repeat loci. Removal of negative torsion by Top1 prevents stretches of singlestranded DNA from folding into triplex, cruciform, and hairpin non-canonical secondary
structures. The hairpin-forming CAG trinucleotide repeats are found at human genes
associated with the neurological disorders Hungtington’s disease and spinocerebella ataxia.
The manifestation of these diseases is dependent on the expansion of the repeat sequences,
which in turn is associated with the topological and structural changes at these genomic loci
due to non-B DNA structure formation. In a screen of small molecules, Top1-inhibitors were
identified as inducing the expansion of CAG trinucleotide repeats in a human cell culture
system (Hubert et al., 2011). This was confirmed by separate work which showed that the
knock-down of Top1 significantly elevated the instability of a large CAG-repeat in a human
fibrocarcinoma cell line (Nakatani et al., 2015). By removing the supercoils generated during
the transcription of these sequences, Top1 likely prevents the formation of pathological nonB DNA structures and helps maintain stability at these unusual repetitive sequences. Another
non-B structure of interest is the four-stranded G-quadruplex DNA or G4 DNA. Held together
by the Hoogsteen bonds among four guanine bases forming a ring-like structure called a Gquartet or tetrad, G4 DNA is composed of multiple runs of guanines forming multiple Gquartets stacked on top of each other (Figure 1) (Bochman et al., 2012). The significance of
G4 DNA as a source of genome instability has recently become evident with the
bioinformatics studies finding G4 motifs, along with other non-B DNA forming sequences, to
be highly enriched at chromosomal translocation hot spots found in cancers (Katapadi et al.,
2012; Bacolla et al., 2016). At BCL2 and c-MYC, two genes known to be involved in recurrent
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blood cancers, G4 motifs are located close to the major chromosomal break point region
(Katapadi et al., 2012). A high density of G4 motifs is also present in BCR (B-cell receptor) or
the immunoglobulin heavy chain (IgH) loci, which are frequently involved in genome
rearrangements and other changes in blood cancers. In mouse B lymphocytes, a decrease in
the protein level of Top1 resulted in elevation in the class switch recombination (CSR) at IgH
loci (Kobayashi et al., 2009; Kobayashi et al., 2011). Chromosomal translocation between IgH
locus and c-Myc is also increased by the knock down of either Top1 or the chromatin
remodeler SMARCA4, which is required for the efficient recruitment of Top1 to the chromatin
(Husain et al., 2016). The decrease in the recruitment of Top1 to the switch regions was
concurrent with the increase in the negative helicity at the same locus as measured by the
incorporation of modified psoralen molecules that bind preferentially to underwound DNA.
CSR initiates with the activation of transcription of the switch sequences that are unusually
G/C-rich and contain multiple runs of guanines capable of folding into G4 DNA. Increased
propensity for G4 DNA folding at these sequences could explain the elevation in CSR and in
IgH/c-Myc translocation observed with reduced Top1 levels. Similarly, when a fragment of
IgH switch region was embedded into the yeast genome, the rate of recombination occurring
at this sequence was significantly elevated in the absence of Top1 (Yadav et al., 2014; Yadav
et al., 2016). The importance of Top1 function in preventing the detrimental effect of G4 DNA
was confirmed in human cells where Top1 was shown to protect cells from the genotoxic
effect of G4-binding small molecules (Zyner et al., 2019).
1.4 Top1 Binding G4 DNA
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In addition to playing a role in suppressing the formation of non-B DNA structures by
preventing the accumulation of negative supercoils, a handful of studies demonstrated that
Top1 can also physically bind to non-B DNA structures including G4 DNA (Thiyagarajan et al.,
1998; Arimondo, 2000; Marchand et al., 2002; Shuai et al., 2010). The first strong evidence of
human Top1 interaction with G4 structures is described in studies by Arimondo et al., in which
an electrophoretic mobility shift assay was used to show that purified human Top1 binds to
preformed intermolecular and intramolecular G4 structures (Arimondo et al., 2000).
Interestingly, this same study uncovered that Top1 promotes the formation of intermolecular
G4 structures. When oligonucleotides (oligos) containing stretches of five or six consecutive
guanines were incubated with purified human Top1, a protease-resistant four-stranded
intermolecular complex of slower mobility was formed. This G4-formation activity was
specific to Top1 and not observed with Top2, histone H2A, or BSA. Another set of experiments
using human Top1 further confirmed that Top1 binds to G4 DNA-forming oligos as well as Grich DNA and RNA oligos (Marchand et al., 2002). This study also showed that the cleavage of
duplex DNA by human Top1 is inhibited by the presence of intermolecular or intramolecular
G4 structures, and that this inhibition is due to the binding of Top1 to G4 DNA. It was also
shown that duplex DNA cleavage by Top1 is inhibited by single-stranded, non-G4 capable DNA
and RNA oligos containing stretches of two or three consecutive guanines. Pre-formed G4
oligos or guanine-rich single-stranded oligos were not cleaved by Top1. More recently, an
effort to find oligonucleotide aptamer inhibitors of human Top1 confirmed that a variety of
DNA oligos forming G-quadruplexes or quadruplex-duplex hybrids bind Top1 and compete it
away from its substrate, dsDNA (Shuai et al., 2010). Many proteins have so far been identified
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as G4 DNA binding proteins. The protein-G4 DNA interactions can roughly be separated into
three categories according to their effect on the stability of G4 structures; (1) promoting G4
DNA formation (yeast Rap1 and human thrombin) (2) stabilizing G4 DNA (murine nucleolin
and human Ku protein) and (3) G4 DNA destabilizing (RecQ helicases BLM, WRN, and Sgs1)
(Fry, 2007). More recently, a transcription factor Sub1 was identified as a potent G4 DNA
binding protein that indirectly leads to destabilization of G4 via recruitment of the helicase
Pif1 (Gao et al., 2015) (Lopez et al., 2017). Sub1 or its mammalian homolog PC4, previously
characterized as a single-strand DNA binding protein, binds to G4 DNA with a low Kd of ~2
nM but does not promote or disrupt G4 DNA folding (Griffin et al., 2017). Wildtype Top1,
based on the experiments reported in Arimondo et al. can be considered to be in the category
of proteins promoting G4 DNA formation (Arimondo et al., 2000; Fry, 2007). In the future, it
will be interesting to uncover how Top1 binds to G4 DNA structures. According to the X-ray
crystal structure published, Top1 forms a tight, bi-lobed clamp around duplex DNA upon
binding (Redinbo et al., 1998). Since there is a significant difference between the diameters
of duplex DNA and G4 DNA, which are approximately 2 nm and 2.4 – 2.8 nm, respectively (Do
et al., 2011; Heddi and Phan, 2011; Amrane et al., 2012), the Top1–G4 DNA complex possibly
adopts a very distinct conformation from Top1-dsDNA.
1.5 Functional Consequence of Top1-G4 DNA Binding
1.5.1 G4 Oligos as Top1 Inhibiting Aptamers
One possible functional consequence of the specific, high-affinity Top1–G4
interaction is the application of G4-forming oligos or aptamers as inhibitors of Top1.
Aptamers are small single-stranded DNA or RNA oligos that are selected for a high affinity
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interaction with a specific target of interest (Platella et al., 2017). Aptamers targeting proteins
or other biologically relevant molecules have been selected by screening libraries of DNA or
RNA oligos and further studied for their potential therapeutic application. Since it was first
discovered that Top1 binds and is inhibited by G4-forming oligos (Arimondo, 2000; Marchand
et al., 2002) other similar results have been reported (Shuai et al., 2010; Ogloblina et al., 2015;
Ogloblina et al., 2018). First, using purified Calf Thymus Top1, Shuai et al. characterized
fourteen different guanine-rich oligos capable of forming either G-quadruplexes or
quadruplex-duplex hybrids and showed that all of the oligos act as competitive inhibitors of
Top1 catalysis (Shuai et al., 2010). The inhibitory effect of these G4 aptamers were
significantly more potent when they were treated with heat-cooling in presence of KCl to fold
into G4 conformations. The IC50 of the G4-formed aptamers ranged from 0.1 to 2.7 µM. Top1
activity can be inhibited by small molecules such as camptothecin (CPT) that stabilize the
Top1-cleavage complex (Top1-cc) and inhibit the ligation of the nicked substrate (Megonigal
et al., 1997; Pommier et al., 2010). The mechanism of Top1 inhibition by the G4 aptamers,
however, appeared to be mediated by the inhibition of the Top1-substrate binding. When
Top1 was incubated with a mixture of a G4-forming aptamer and dsDNA substrate (i.e.,
pBR322 plasmid DNA), Top1 preferentially bound to the G4 aptamer (Shuai et al., 2010). The
inhibitory effect of G4-forming oligos on Top1 activity was further confirmed in a study of
guanine-rich microsatellite repeat sequences found in the human genome (Ogloblina et al.,
2015). In this work, highly thermostable G4-forming oligos d(GGT)4 and d(GGGT)4 were added
to Hela cell extract to determine how each of these oligos affects the Top1-mediated
relaxation of supercoiled pUC19 plasmid DNA. Compared to a random oligo of similar length,
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which showed no effect in the relaxation assay, both G4 oligos d(GGT)4 and d(GGGT)4 were
very effective in inhibiting Top1 with the IC50s of 0.63 and 0.12 µM, respectively. Another Grich oligo d(GT)16, which is not capable of forming a thermostable G4 structure, did not inhibit
Top1 activity, indicating the structure-specific nature of inhibition. When non-G4 flanking
sequences were added to the effective inhibitor d(GGGT)4, the thermostability was decreased
with the resulting Tm of 85 and 73 °C, respectively, for d(GGGT)4 and d(CACTGG-CC-(GGGT)4TA-CCAGTG). But the longer oligo proved to be a more effective Top1 inhibitor with IC 50 of
0.08 µM. In another study, six different guanine-rich aptamers were tested for their inhibitory
effect on human Top1 (Ogloblina et al., 2018). These aptamers were previously designed to
target other oncogenic proteins, namely STAT3, SP1,VEGF, NCL, and SHP-2, and commonly
formed either parallel or anti-parallel G4 DNAs that are significantly stabilized by the presence
of potassium cation as expected. All of these aptamers were very effective in inhibiting the
activity of Top1 in a plasmid-relaxation assay with the IC50 in the low µM range. They were
even more effective in inhibiting Top1 when compared to the aptamer first identified as a
Top1-specific inhibitor by Shuai et al. (Shuai et al., 2010). The inhibition of Top1 by the G4
oligos was correlated with the inhibition of DNA replication, and this antiproliferative effect
was specific to cancer cells (Ogloblina et al., 2018). Although the physical interaction between
the G4-capable aptamers and Top1 was not determined in these studies, the specific nature
of the inhibition strongly suggests that the competitive binding of the aptamers to Top1
underlies the inhibition of the catalytic activity.
1.5.2 The Biological Consequence of the Top1 Interaction with G4 DNA
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While Top1-binding to G4 DNA is an interesting property to exploit in the use of G4forming aptamers to target Top1 as a therapy, whether Top1 binding to endogenous,
genomic G4 structures serves a biological function is not yet clear. Chromatin
immunoprecipitation experiments conducted in yeast revealed that Top1 is enriched at
telomeres, which contain G4 DNA forming sequences (Lotito et al., 2008). This study also
demonstrated that the expression of the yeast Top1 catalytic mutant, yTop1Y727F, in a top1∆
background elevates H4 K16 histone acetylation at genomic regions located proximal to
telomeres. These results suggest that Top1 regulates transcription of telomere proximal
genes and that the catalytic activity of Top1 is required for this function. It is possible that
Top1 regulates chromatin state and expression of genes near telomeres through G4 DNA
binding. Another possible function of the Top1–G4 DNA interaction is in the recruitment of
G4-resolvases to the genomic G4 structures. Human Top1 was shown to interact with the
Werner helicase, which can unfold G4 structures (Lebel et al., 1999; Mendoza et al., 2016),
suggesting that it is possible that Top1 promotes the localization of the Werner helicase to
G4 structures through its own interaction with G4 DNAs. Top1 also interacts with the SV40 T
antigen, which harbors DNA helicase activity (Stahl et al., 1986). These examples of Top1
interaction with the Werner helicase and the SV40 T antigen suggest further studies should
be conducted to determine whether Top1 interacts with additional DNA helicases,
particularly those helicases capable of unwinding G4 DNAs.
1.5.3 Interaction Between Mutant Top1 and G4 DNA In Vivo
Even though the interaction of G4 DNA with functional Top1 may result in
transcriptional regulation or G4 structure resolution, another observation suggests that the
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interaction of G4 DNA with Top1 catalytic mutants is deleterious. Human and Saccharomyces
cerevisiae Top1 use amino acid residues tyrosine 723 and tyrosine 727, respectively, to
undergo the nucleophilic attack of the phosphodiester DNA backbone effectively nicking the
DNA (Redinbo et al., 1998). However, if either of these residues is mutated to a phenylalanine,
Top1 can bind, but not nick DNA. Interestingly, expression of Top1Y727F in yeast results in
exacerbated recombination at a model G4-motif (Yadav et al., 2016). This elevated G4induced recombination observed in the presence of Top1Y727F is significantly greater than
the G4-induced recombination observed in a top1∆ yeast strain and is dependent on
transcription. The effect of Top1Y727F on G4-induced genomic instability is surprising as the
level of superhelical tension accumulation is expected to be similar in a top1∆ strain and a
Top1Y727F-expressing yeast strain. Therefore, the increase in G4-induced genomic instability
observed in a Top1Y727F-expressing yeast strain compared to a top1∆ strain must be from
another factor in addition to negative supercoil accumulation. Yeast Top1Y727F was shown
to be enriched at telomeres in chromatin immunoprecipitation experiments (Lotito et al.,
2008) and, in vitro, it preferentially binds to G4 oligos over a C-rich or a random control oligo
(Table 1, Figure 3). Top1Y727F binding and stabilizing G4 structures would explain the highly
elevated genomic instability at G4-motifs. Further, while WT Top1 may bind to G4 structures
transiently, the lack of catalytic activity after DNA binding by yeast Top1Y727F may result in
the trapping of Top1Y727F on G4 structures.
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Oligo
G4-1
G4-2
C
T

Sequence
5’ GAGCTGGGGTGAGCTGGGCTGAGCTGGGGTGAGCTGGGCTGAGCT
5’ AGGGCTCTGCCTTGGGGGGGGGGCAGGAAGGGA
5’ AGCTCAGCCCAGCTCACCCCAGCTCAGCCCAGCTCACCCCAGCTC
5’ GCACGCGTATCTTTTTGGCGCAGGTG

Table 1. Sequences of DNA oligonucleotides used in yeast WT Top1 and Top1Y727F pull
downs in Figure 3. Guanines are underline and italicized.
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Figure 3. Yeast WT Top1 and Top1Y727F bind to G4 structures. Western blots of pulldowns
of WT Top1-3XFLAG (top) and Top1Y727F-3XFLAG (bottom) from yeast whole cell lysates with
biotinylated DNA oligonucleotides (MilliporeSigma). Biotinylated oligonucleotides G4-1, G42, C, and T were conjugated to Streptavidin-Coupled M-280 Dynabeads. Following the
mechanical lysis of yeast cells with a Biospec Mini-bead-beater, the cell lysate was collected
and sonicated. Oligo-conjugated Dynabeads were incubated at 4 °C overnight with the yeast
extract, washed, and then eluted by boiling in 1XSDS-PAGE loading buffer followed by
immunoblotting analysis using anti-FLAG antibody to detect 3XFlag-tagged Top1 or
Top1Y727F.
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Another way Top1Y727F could increase the instability of G4 DNA-forming genomic
loci is by binding to G4 DNA and then preventing G4 resolvases from accessing the structure.
This mechanism has been described for the human protein nucleolin (NCL) (Indig et al., 2012).
NCL is an essential nuclear/nucleolar protein with multiple known functions (Tajrishi et al.,
2011). Most prominently, NCL is involved in the ribosomal RNA maturation. Mammalian NCL,
however, was also shown in vitro to be capable of high-affinity binding to G4 DNA with Kd in
the low nM range (Dempsey et al., 1999; Hanakahi et al., 1999). More recently, the specific
interaction between NCL and the G4 DNA formed from the (GGGGCC)n repeat in the human
C9orf72 gene was demonstrated in vivo (Haeusler et al., 2014). Expansion of the (GGGGCC)n
repeats in the C9orf72 gene is associated with the neurological disorders amyotrophic lateral
sclerosis (ALS) and frontotemporal dementia (FTD). An in vitro helicase assay has shown that
G4 DNA, when in complex with NCL, becomes resistant to unwinding by Werner helicase, a
G4 resolvase (Indig et al., 2012). If G4 structures are left unresolved, they could be potent
blocks to DNA replication leading to genome rearrangements (Weitzmann et al., 1996; Sarkies
et al., 2010; Paeschke et al., 2011). Similarly, it has been shown that Nsr1, the yeast homolog
of NCL, binds to G4 structures in vitro and in vivo (Singh et al., 2020). Deletion of the NSR1
gene or the expression of a truncated form of Nsr1 missing an important G4 DNA-binding
domain in a nsr1∆ background significantly reduces recombination at a model G4-motif. This
indicates that Nsr1, like NCL, increases G4-induced instability through G4 binding. Of note,
NSR1-deletion also reduces G4-induced recombination in a TOP1Y727F background,
however, not to wild type levels as observed in top1∆ nsr1∆ strain (Singh et al., 2020).
Because Nsr1 and Top1 physically interact (Azevedo et al., 2015), it is possible that these two
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G4 DNA binding proteins form a higher-order complex to increase G4-induced instability in a
synergistic manner.
1.5.4 DNA-Protein Complexes as DNA Replication Barriers
Replication forks can stall and collapse at DNA lesions leading to genome instability.
Such genotoxic impediment to replication can include DNA–protein complexes (Gadaleta and
Noguchi, 2017). Especially, proteins covalently trapped on DNA are known to be natural
replication blocks. During the removal of helical tension, Top1 forms a phospho-tyrosyl bond
with the 3’ end of nicked DNA, and this covalent DNA–protein complex is termed a Top1cleavage complex (Top1-cc) (Redinbo et al., 1998). After strand swiveling has occurred, the 5’
OH of the nicked strand attacks the phosphor-tyrosyl bond connecting Top1 to DNA which
results in the ligation of DNA and release of the enzyme. Top1-ccs, such as those induced by
the Top1 poison camptothecin (CPT) and its derivatives, block DNA replication and induce
DNA strand breaks and recombination (Pommier et al., 2010). On the other hand, there are
examples of non-covalent proteins-DNA complexes that block DNA replication machinery in
both prokaryotes and eukaryotes. In Escherichia coli, a protein called Tus binds to Ter sites
within DNA, and this DNA–protein interaction terminates replication in a unidirectional
manner to prevent the collision of replication forks approaching each other in a head-on
orientation (Hill et al., 1987; Hill et al., 1989; Kamada et al., 1996). The replication fork barrier
created by the Tus-Ter interaction functions to ensure proper replication termination of the
circular chromosome (Mohanty et al., 1996). Another example of non-covalent DNA–protein
complex that can block replication in E. coli is the array of lacI repressor molecules bound to
Lac operon (Payne et al., 2006). In eukaryotes, tight DNA–protein interactions that inhibit
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DNA replication occur at the highly transcribed genomic loci that encode ribosomal RNA. In
S. cerevisiae, similar polar Replication Fork Blocks (RFBs) are generated at each of the 150–
200 rDNA tandem repeats located at Chromosome XII (Brewer and Fangman, 1988). Fob1
binding at the rDNA array on chromosome XII is an example of the DNA–protein complex
serving as replication fork block (Kobayashi and Horiuchi, 1996). In yeast cells defective for
the DNA helicase Rrm3, replication was blocked at discrete genomic loci including known
heterochromatin regions such as centromeres and silent mating type loci but also at tRNA
genes, inactive replication origins, and transcriptional silencers (Ivessa et al., 2003). These
regions are characterized by the non-histone DNA–protein complexes, indicating that highaffinity DNA–protein complexes can form replication blocks or barriers.
DNA secondary structures such as G4 DNA also form potent replication barriers
(Gadaleta and Noguchi, 2017). G4 DNA in the template strand stalls the replicative
polymerases in vitro and translesion DNA polymerases such as the mammalian Pol eta and
kappa and bacterial Pol IV are necessary for continued synthesis (Woodford et al., 1994;
Sarkies et al., 2010; Eddy et al., 2015; Eddy et al., 2016; Berroyer et al., 2019). Replication in
yeast is impeded at G4 motifs when the G4 DNA helicase Pif1 is disrupted (Ribeyre et al.,
2009; Paeschke et al., 2011; Paeschke et al., 2013). G4 DNA stabilized by small molecule
ligands such as pyridostatin (PDS) or PhenDC3 increase the instability at G4-forming
sequences in eukaryotic genomes indicating that the stability of G4 DNA correlates with its
efficacy as replication block (Piazza et al., 2010; Rodriguez et al., 2012; Piazza et al., 2015;
Moruno-Manchon et al., 2017). Similarly, a more problematic obstacle to replication is
expected when G4 DNA is in complex with a high-affinity binding protein such as the Top1
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catalytic mutant (Top1Y727F), which binds to G4 DNA to form a stable complex (Table 1,
Figure 3). When the Top1Y727F mutant was expressed in top1∆ yeast cells, there was a
significant and G4-specific elevation in the recombination rate (Yadav et al., 2016). On the
other hand, expression of the Top1T722A mutant, which can competently cleave DNA but is
defective in the re-ligation step leading to the formation of Top1-ccs, resulted in a modest
elevation in recombination independent of the sequence. CPT-treatment also led to a nonspecific elevation of recombination. Together, these data indicate that the G4-specific
elevation of recombination upon expressing Top1Y727F is not due to inhibition of Top1
catalytic activity or due to increased formation of Top1-ccs. The preferential binding of the
mutant protein to G4 DNA is then one mechanism possibly underlying the sharp increase in
G4-specific recombination following the expression of Top1Y727F. That is, Top1 mutants
bound tightly to G4 DNA structures could be strongly disruptive to replication and
recombinogenic in a manner similar to those covalent and non-covalent DNA–protein
complexes that function as replication barrier sites.
While proteins that are covalently trapped or are tightly bound to DNA are known to
block replication, they can be resolved to prevent genomic instability in several different
manners. In yeast, the protease named weak suppressor of SMT3 protein 1 or Wss1, degrades
proteins trapped on DNA, including Top1-ccs (Stingele et al., 2014). Top1-ccs become
SUMOylated in yeast, and the SUMOylation of proteins trapped on DNA by DNA-bound SUMO
ligases directs and enhances the recruitment of Wss1, which contains SUMO-interacting
motifs. Wss1 degrades DNA-trapped proteins almost entirely, leaving behind small peptide
remnants that are further processed by the proteasome or are bypassed during replication
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by translesion polymerases. The human homolog of Wss1 is a protein named Spartan; the
loss of Spartan leads to an accumulation of unrepaired Top1-ccs in human cells (Stingele et
al., 2016; Vaz et al., 2016; Maskey et al., 2017). However, instead of SUMO-interacting motifs
as in yeast Wss1, the recruitment and activity of Spartan is regulated by its ubiquitin-binding
domain (Stingele et al., 2017). In the future, it will be interesting to explore if Top1 mutants
trapped on G4 DNAs are modified by SUMOylation and/or ubiquitylation and subsequently
processed by Wss1 and Spartan in S. cerevisiae and humans, respectively.
1.6 Top1 Mutants in Cancer Cells and G4-Induced Genomic Instability
Top1 has long been the molecular target of chemotherapeutics. CPT and CPT
derivatives are widely used to treat many cancers, and work by stabilizing Top1-ccs as
mentioned above. Cancer cells can become resistant to CPT through multiple different
mechanisms (Beretta et al., 2013). First, consistent with cell culture experiments
demonstrating that the reduced levels of Top1 confer resistance to CPT, cancers relapsing
after chemotherapy spontaneously become resistant to CPT through reduced expression of
Top1 (Burgess et al., 2008; Zuco et al., 2010). Cancer cells can also become impervious to CPTtreatment through mutations of Top1 that reduce the ability either to bind to duplex DNA or
to cleave duplex DNA following binding. A study conducted in yeast found intragenic
suppressors of the yeast Top1T722A mutation (Hann et al., 1998), which mimics the cytotoxic
activity of CPT. One such suppressor mutant, yeast Top1G369D, has a critically reduced
duplex DNA binding ability. Another study found that T729 is mutated in a human lung cancer
cell line that is resistant to the CPT analog irinotecan (Kubota et al., 1992). Further
investigation demonstrated that expression of the human Top1T729K and Top1T729E
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mutants in yeast confers resistance to CPT, and that these Top1 mutants are defective in
duplex DNA binding (Losasso et al., 2008). Other studies have demonstrated that Top1
catalytic mutants, which harbor reduced duplex DNA cleavage abilities, exist in cancer cell
lines and cancer patients. The homozygous Top1G365S mutant, which was found in a colon
cancer cell line that is resistant to the active metabolite of irinotecan, displays 50% reduced
catalytic activity (Arakawa et al., 2006). Another mutant, Top1W736Stop, was found in a nonsmall cell lung cancer patient treated with irinotecan and is predicted to have reduced
catalytic activity (Tsurutani et al., 2002). A large number of Top1 mutations identified in CPTresistant cancer cells and patient samples remain uncharacterized. Some of the mutations
located in the catalytic C-terminal domain of human Top1 (amino acids 713–765) are listed in
Table 2. Although these are missense or nonsense mutations located in the catalytically
critical domain of the protein, the residues in the C-terminal domain also participate in the
contact with dsDNA (Stewart et al., 1998; Redinbo et al., 1998). For a majority of those listed
mutations, whether each of the mutations results in the loss of DNA cleavage or DNA binding
activity of Top1 has not been studied. Of note, additional mutations not listed that are located
in the core domain of Top1 can also result in reduced enzyme catalysis, like the G365S
mutation found in a CPT-resistant colorectal cancer cell line as described above (Arakawa et
al., 2006). Top1 is required to suppress recombination and instability at a highly transcribed
G4-motif in yeast and suppresses the genotoxic effect of G4-ligands in human cells (Yadav et
al., 2014; Yadav et al., 2016; Zyner et al., 2019). siRNA-mediated knock-down of Top1 in
mouse cells elevates CSR and chromosomal translocations involving the G4 DNA-forming IgH
switch region sequences (Kobayashi et al., 2011; Husain et al., 2016). The reduced levels of
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Top1 in the CPT-resistant human cancer cells is then expected to disrupt its normal cellular
role of preventing excess levels of negative supercoiling at highly transcribed loci and to
thereby elevate the accumulation of non-B DNA formation including G4 DNA. The reduced
Top1 levels and also the reduced Top1 function in cells with DNA-binding defective mutants
(e.g., Top1T729K and Top1T729E) very likely manifest in elevated genome instability
associated with the formation of G4 DNA and other non-B structures. However, in those CPTresistant cancers with Top1 mutants that are catalytically defective but competent for DNA
binding, additional consideration must be made according to an interesting piece of
preliminary data from yeast studies. Expression of the yeast Top1 mutant Y727F further
exacerbates the instability at G4 DNA-forming genomic loci beyond the loss of Top1 function
by additionally binding to G4 DNA and other G4 DNA-binding proteins (Azevedo et al., 2015;
Yadav et al., 2016; Singh et al., 2020). It needs to be examined whether a similar G4-specific
deleterious effect is produced with the expression of human Top1 mutants such as
Top1G365S and Top1W736Stop mutants, which can bind but not cleave DNA. Incidences of
secondary cancers following treatment with the CPT-derivative irinotecan have been
documented. In one case, a patient with X-linked agammaglobulinemia and metastatic
colorectal cancer experienced an increase in cancer progression and severe hypocalcemia
after treatment with irinotecan (Li et al., 2019). Another study revealed that a colon cancer
patient developed secondary acute promyelocytic leukemia following treatment with
irinotecan and oxaliplatin (Merrouche et al., 2006). While both Top1 mutations and
secondary genomic rearrangements have been discovered in cancer patients treated with
CPT or CPT derivatives, a link between these documented Top1 mutations and G4-induced
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secondary genomic rearrangements has not been studied. In the future, it will be important
to uncover if cancer cells from patients treated with CPT or CPT derivatives have increased
secondary genomic rearrangements at G4-forming loci. The increased potential for G4induced genomic instability due to cleavage-defective Top1 catalytic mutants could render
cancers more complicated to treat and potentially worsen patient outcomes.

30

31

Table 2. A selected list of human Top1 C-terminal mutations from studies, cancer cell lines,
and patient samples. ICGC, International Cancer Genome Consortium (https://icgc.org);
COSMIC, Catalogue of Somatic Mutations in Cancer (see reference Tate et al., 2018 and
cancer.sanger.ac.uk).
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1.7 Summary and Significance
Given the significance of G4 DNA-forming sequences in the development of cancerassociated genome rearrangements, it is very important to study how guanine-run containing
sequences are converted into hotspots of genome instability. As shown in yeast and
mammalian systems, Top1 plays an essential role in preventing genome instability at G4 DNAforming loci by removing transcription-associated superhelical tension and maintaining a
proper topological conformation (Figure 4 A-B). Furthermore, newly emerging evidence
indicate that Top1 can specifically and preferentially interact with G4 DNA. The interaction
between Top1 mutants and G4 DNA, however, could lead to the formation of pathological
complexes that interfere with efficient DNA replication (Figure 4C-D). Based on a preliminary
observation obtained from a yeast model system linking the expression of a Top1 mutant
with acutely elevated G4 DNA-associated genome instability, further characterization of
human Top1 mutants, particularly those arising in CPT-treated cancer cells, could shed light
on the significance of the interaction between mutant proteins and non-B DNA structures.
On the other hand, the significance of the Top1–G4 DNA interaction can be viewed from a
very different perspective. Multiple recent studies suggest that G4 DNA-forming oligos can
preferentially bind and interfere with the activity of Top1, which has been a very important
target of anti-cancer therapy. This property can be exploited to develop a new class of drugs
targeting Top1 that can serve as an alternative and a complement to the Top1-poisoning CPT
and CPT derivates.
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Figure 4. A model of genome instability induced by co-transcriptionally formed G4 DNA and
the effect of Top1 activity and mutation. RNAP—RNA polymerase complex. Dotted line—the
nascent transcript. (-)—negative tension behind the transcription complex. (+)—positive
tension ahead of the transcription complex. Top1mut—Top1 mutant.
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Chapter 2: Materials and Methods

Note: Portions of this chapter were derived from a manuscript accepted for publication in
Microbial Cell. BERROYER, A., BACOLLA, A., TAINER, J. A., and KIM N. 2022. Cleavage-defective
Topoisomerase I mutants sharply increase G-quadruplex-associated genomic instability.
Microbial Cell, Accepted January 19th 2022. microbialcell.com is the property of the Shared
Science Publishers OG. Unless otherwise stated, all articles and corresponding materials
accompanying them that are published by Shared Science Publishers OG on this Web Site are
licensed by their respective authors for your use and distribution provided you cite the original
source as specified in the corresponding Creative Commons Attribution License. Creative
Commons Attribution License weblink: https://creativecommons.org/licenses/by/4.0/.
Article available at http://microbialcell.com/researcharticles/2022a-berroyer-microbial-cell/.
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2.1 Protein Purification
HIS- and FLAG-tagged BG4 antibody was expressed in E. coli BL121 (DE3) cells from
the pSANG10-3F-BG4 plasmid (Addgene; Cat #55756). BG4-HIS-FLAG protein was purified
using the protocol from Moruno-Manchon et al., 2017. Briefly, one liter of E. coli cells
harboring pSANG10-3F-BG4 were grown shaking at 37 °C until an OD600 of 0.8-0.9 was
reached. Then IPTG was added to the culture to a final concentration of 1 mM and cells were
grown shaking at 30 °C for 15-17 hours. Next, cells were collected by centrifugation and
pellets were frozen at -80 °C. Cell pellets were resuspended in NP40 buffer (25 mM Tris-HCl
pH 8.0, 100 mM NaCl, 10% glycerol, 1% NP40, 10 mM imidazole, and 1X Protease Inhibitor
Cocktail II (GenDEPOT; Cat #P5101-005)) then lysed via sonication (QSONICA sonicator; 2 sec
ON, sec OFF, 6 min. at 30% amplitude output). Following sonication, lysates were clarified by
centrifugation at 4°C for an hour at 16,000 rcf. Then, 2 ml of HisPur™ Ni-NTA Resin
(ThermoFisher) was equilibrated with NP40 buffer, added to the clarified lysate, and
incubated with the clarified lysate overnight rotating at 4 °C. The next day, the lysate was
passed through a column to collect the HisPur™ Ni-NTA Resin. The HisPur™ Ni-NTA Resin was
washed with 50 ml of wash buffer (NP40 buffer + 40 mM imidazole). HIS tagged BG4-FLAG
was eluted from the HisPur™ Ni-NTA Resin by the passing of 10 ml of elution buffer (NP40
buffer + 250 mM imidazole) through the Ni resin packed column. Purified BG4 elutions were
analyzed by resolving elution samples via SDS PAGE followed by Coomassie gel staining.
2.2 Yeast Strain and Plasmid Construction
Yeast strains used in this study were derived from YPH45 (MATa, ura3-52 ade2-101
trp1∆1) and the construction of the pTET-lys2-GTOP (SµG4-GTOP) and –GBTM (SµG4-GBTM)
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reporter containing strains was previously described (Kim and Jinks-Robertson, 2011). A
schematic of the SµG4-GTOP and SµG4-GBTM recombination reporter constructs is in Figure
5. Unless noted otherwise, all yeast gene knock out and Top1 and Nsr1 epitope-tagged strains
were constructed by one-step allele replacement where parental strains were transformed
by the LiOAc method (Ito et al., 1983) with PCR products containing selectable marker
cassettes. All PCR primers used in strain construction and allele replacement are listed in
Table 3. All tagged and mutated strains were confirmed by Sanger sequencing. The
construction of yTOP1Y727-3XFLAG strains was previously described (Yadav et al., 2016). The
yTOP1S733E-3XFLAG mutant strains were created using the “delitto perfetto” method
(Storici and Resnick, 2006); yTOP1-3XFLAG strains were first transformed with PCR product
created with the Top1S733E F and Top1S733E R primers to insert the URA3 marker near the
S733 codon. A second transformation with a duplex oligo containing the S733E mutant codon
(primers Top1S733E and Top1S733E RC annealed) was performed, resulting in the loss of the
URA3 marker and 5-Fluoroorotic acid resistance. The NSR1-6XHA strains were constructed by
transformation with PCR product consisting of the pHYG-AID*-6HA plasmid (Morawska and
Ulrich, 2013) amplified with the Nsr1-6XHA F and Nsr1-6XHA R primers. The Nsr1ΔRGG-6XHA
strains were constructed by transformation with PCR product consisting of the pHYG-AID*6HA plasmid amplified with the Nsr1ΔRGG-6XHA F and Nsr1ΔRGG-6XHA R primers.
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Figure 5. Schematic of SµG4-GTOP and SµG4-GBTM yeast recombination reporters. The
guanines of SµG4 are located on the non-transcribed strand in GTOP, while the guanines of
SµG4 are located on the transcribed strand in GBTM. GTOP is G4-capable during transcription
while GBTM is not. The GTOP and GBTM constructs were inserted into a LYS2 gene that is
controlled by a doxycycline repressible promoter and block production of lysine. If a strand
break occurs in GTOP or GBTM, a truncated version of the LYS2 gene is used as a template for
recombination and lysine will be produced. Recombination rates at GTOP and GBTM are
determined by scoring LYS+ recombinants. RNAP = RNA polymerase complex. Nascent mRNA
is denoted by red line.
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Table 3. Primers used for strain construction in this work.
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The pGAL-BG4-FLAG yeast expression plasmid was created by amplifying the coding
sequence of BG4 harboring a C-terminal 3X FLAG-tag from the pSANG10-3F-BG4 vector
(Addgene Cat #55756) via PCR. The BG4-3XFLAG PCR product was then inserted into the
pRS426 2 micron vector (Christianson et al., 1992) containing a galactose inducible promoter
(pGAL) and a URA3 marker using Spe1 and EcoR1 restriction sites. The Top1Y727F-HA yeast
expression plasmid (pAR7-HA) (Lotito et al., 2008) used for ChIP RT-qPCR experiments was a
gift from the Capranico lab at the University of Bologna in Bologna, Italy. The pADH1-Nterm
Nsr1 (N-term Nsr1; amino acids 1-171) and pADH1-Cterm Nsr1 (C-term Nsr1; amino acids
172-414) plasmids were gifts from A. Saiardi from the University College London, UK (Azevedo
et al., 2015). The pADH1-Nsr1 (Nsr1 FL; amino acids 1-414) plasmid was constructed by
replacing the Nsr1 N-terminus DNA sequence from pADH1-Nterm Nsr1 with the full length
Nsr1 open reading frame that was PCR-amplified from the pRS316-derived Nsr1-expression
CEN vector that has been previously described (Singh et al., 2020).
2.3 Western Blotting
Yeast whole cell lysates were prepared for western blotting as previously described
(Kushnirov, 2000). Whole cell lysate samples were centrifuged and resuspended in 2X SDS
sample buffer and boiled for 10 min at 95 °C before being resolved on 4-20% SDS-PAGE gels
(Bio-Rad; Cat# 456-1093). Proteins were transferred to PVDF membrane using a Trans-Blot®
SD cell machine (Bio-Rad; Cat# 170-3940) and then probed with either an α-FLAG antibody
conjugated to horse radish peroxidase (HRP) (Sigma; Cat# A8592), an HRP-conjugated α-HA
antibody (Sigma; Cat# H6533), an α-HRP-conjugated GAPDH antibody (Invitrogen; Cat# MA515738-HRP), or a primary α-GST antibody (Invitrogen; Cat# MA4-004) followed by incubation
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with a secondary HRP-conjugated α-mouse Ig antibody (R&D Systems; Cat# HAF007) as
indicated in the respective figures. Blots were visualized by treatment with GenDEPOT WestQ Femto ECL (Cat# W3680-010) and a Bio-Rad ChemiDoc™ MP imaging system. Quantification
of Top1 and Nsr1 protein levels was performed using Image Lab software. The pixel volumes
of FLAG- or GST-bands after subtracting background were divided by GAPDH loading control
pixel volumes. Averages and standard deviations from at least 3 independent experiments
were calculated and a student’s T-test (GraphPad Prism) was used to assess statistical
differences where indicated.
2.4 Cell Survival Spot Assays
Cell survival spotting assays were performed by first growing yeast cells transformed
with either pGAL-BG4-FLAG or the empty vector control (2µ vector with pGAL promoter and
URA3 selectable marker) in 5 mls synthetic complete dextrose media lacking uracil (SCD-ura)
overnight at 30 °C. The next day, cultures were diluted to an OD600 of 0.3 in 5 mls SCD-ura
media and were grown until the culture reached an OD600 of 1. Then, a total of 0.3 OD600 of
cells were taken from each culture and were resuspended in 100 µl of water. The cells were
then diluted 1:10 serially 5 times and 10 µl of each dilution was spotted on plates containing
either 2% glucose, 2% raffinose, 2% raffinose + 0.01% galactose, 2% raffinose + 0.5%
galactose, 2% raffinose + 1% galactose, or 2% raffinose + 2% galactose. Spot assay plates
were imaged every day for 3 days after growth at 30 °C using a Bio-Rad ChemiDoc™ MP
imaging system.
Cell survival spot assays of Top1 mutant yeast cells plated on CPT-containing plates
was conducted as listed above with the following modifications. MUS81-deletion cells were
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grown in 5 mls of liquid YPD media overnight at 30°C shaking. The next day, cultures were
diluted to an OD600 of 0.15 in 5 mls of liquid YPD media and were grown at 30°C until the
cultures reached an OD600 of 0.6-0.7. A total of 0.3 OD600 of cells were collected from each
culture and were resuspended in 100 µl of sterile water. Then, 5 µl of serial 1:10 dilutions of
cells were spotted onto YPD plates containing either 0.35% DMSO, 5 µM CPT + 0.35% DMSO,
or 20 µM CPT + 0.35% DMSO. Spot assay plates were imaged every day for 2 days after growth
at 30 °C using a Bio-Rad ChemiDoc™ MP imaging system. CPT used was purchased from Sigma
(Cat# 208925).
2.5 In vitro DNA Binding Assays
In vitro DNA binding assays were performed as previously described with some
modifications (Gao et al., 2015). Oligos with 5´- and 3´-biotin attachments used in pull downs
were purchased from Sigma. For each sample, 25 pmol of biotinylated oligos were folded by
boiling for 5 min at 95°C in a heat block followed by slow cooling to room temperature in 100
µL of 10 mM Tris pH 7.5 + 100 mM KCl. Folded oligos were incubated while rotating with 6.25
µL of Streptavidin-Coupled M-280 Dynabeads (Invitrogen; Cat# 11205D) that were washed
twice and resuspended in 10 mM Tris HCl pH 7.5 + 1 mM EDTA + 300 mM KCl. After 1 h
incubation at room temperature, oligo-bound beads were washed twice with and
resuspended in 5 mM Tris HCl pH 7.5 + 0.5 mM EDTA + 150 mM KCl and kept at 4°C until
further use. Oligo-bound beads were rinsed once with 1 mL lysis buffer B (50 mM Hepes pH
7.5, 1 mM EDTA pH 8.0, 300 mM KCL, 10% glycerol, 0.05% NP40, 1mM PMSF, 1 mM DTT, and
fungal protease inhibitor cocktail (Sigma; Cat# P8215) (50 µl/ 10 ml)) and were resuspended
in 100 µL lysis buffer B right before being added to yeast whole cell lysates.
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For yeast whole cell lysate preparation, a 5 mL YPD overnight culture was used to
inoculate a 500 mL YPD culture and cells were grown shaking at 30°C until the culture reached
an OD600 of 1.5 – 2.0. A total of 410 OD600 of cells were collected via centrifugation at 4°C
after washing twice with H2O and once with lysis buffer A (50 mM HEPES pH 7.5, 1 mM EDTA
pH 8.0, 300 mM KCL, and 10% glycerol) followed by freezing at -80°C. Frozen pellets were
resuspended in lysis buffer B and lysates were prepared by 4 rounds of bead beating with
acid washed glass beads for 30 sec followed by 5 min of incubation on ice. After bead beating,
lysates were sonicated for 10 cycles of 20 sec ON/40 sec OFF at low amplitude with a
Bioruptor (Diagenode) at 4 °C. Lysates were clarified by centrifugation at 4°C and oligoconjugated streptavidin magnetic beads were added. A magnet was used to pull down beads
after overnight incubation rotating at 4°C followed by four 1 mL washes in lysis buffer B and
elution in 50 µL 2X SDS sample buffer. Subsequent western blot analyses of elutions and input
samples (clarified lysate) were carried out as described above. Pull down/Input was
calculated by dividing the pull-down pixel volumes by the input pixel volumes. Averages and
standard deviations of ratios from 3 independent experiments were calculated and a
student’s T-test (GraphPad Prism) was used to assess statistical differences where indicated.
2.6 Chromatin Immunoprecipitation
ChIP was performed as previously described (Lopez et al., 2017) (Singh et al., 2020).
In short, yeast cells transformed with pGAL-BG4-FLAG, the control vector pRS426, or the
Top1Y727F-HA yeast expression plasmid (pAR7-HA) were crosslinked with 1% formaldehyde
followed by quenching with 136 mM glycine. Cells were lysed by bead beating and sonication
was used to shear the chromatin into ~500 bp fragments using a Bioruptor (Diagenode) with
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the following settings at 4 °C: 5 cycles of 30 sec ON/30 sec OFF at high amplitude. Samples
were incubated with 10 µl of Anti-FLAG® M2 Magnetic Beads (Sigma) or Protein G-Dynabeads
(Life Technologies) conjugated to an α-HA antibody overnight at 4 °C, followed by washing
and cross-link reversal by incubation with proteinase K at 42 °C for 4 hours and 65 °C for 12
hours. DNA was purified with the MiniElute PCR Purification Kit (Qiagen) followed by
quantitative (q) PCR with SensiFAST SYBR no-ROX Mastermix (Bioline) and a CFX Connect
instrument (Biorad). Twelve and a half ng of input or ChIP DNA was used as a template and
0.4 µM of primers were used in each PCR reaction with cycling conditions of 95 °C for 3 min.
followed by 40 cycles of 95 °C for 5 s, 60 °C for 10 s, and 72 °C for 10s. The qPCR primers used
have been previously described (Lopez et al., 2017) (Singh et al., 2020) and target either a
locus that is 100 bp from the SµG4 insertion site (“G4”), a negative control locus ~3 kb from
SµG4 (“3 kb”), or another negative control, non-G4 capable locus (“CAN1”). Fold enrichment
of BG4 and HA-Top1Y727F at the G4 locus relative to the CAN1 locus was calculated for each
sample using Cq values obtained from qPCR and the following equation: 2n (n = (G4 input Cq
average – CAN1 input Cq average) – (G4 IP Cq average – CAN1 IP Cq average)). Fold
enrichment of HA-Top1Y727F at the 3 kb locus relative to the CAN1 locus was calculated for
each sample using the same enrichment equation from above, replacing G4 Cq averages with
3 kb cq averages.
2.7 Immunofluorescence
Immunofluorescence with BG4 was performed as previously described (Pringle et al.,
1991). WT and top1∆ cells transformed with pGAL-BG4-FLAG were grown at 30°C until an
OD600 of 1. Formaldehyde (4%) was added to the culture flask, and cells were crosslinked for
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10 min. at 30°C shaking. After that, cells were collected by centrifugation, resuspended in
40mM KPO4 (pH6.5), 500µM MgCl2, and 4% formaldehyde, and were incubated shaking at 30
°C for another hour. Then, formaldehyde was quenched by addition of 100mM glycine. Cells
were washed twice with 40mM KPO4 (pH6.5) and 500µM MgCl2 and once with 40mM KPO4
(pH6.5), 500µM MgCl2, and 1.2M sorbitol. Cells were then resuspended in 40mM KPO 4
(pH6.5), 500µM MgCl2, and 1.2M sorbitol and were made into spheroplasts by incubation at
37°C for 30 min with 0.6 mg/ml Zymolase 20T (USBiological). Next, spheroplasts were washed
once with 40mM KPO4 (pH6.5), 500µM MgCl2, and 1.2M sorbitol and resuspended in 1X PBS
followed by permeabilization with 0.5% Triton-X for 10 min at room temperature. After
permeabilization, spheroplasts were washed three times with 1X PBS and blocked with 1%
BSA, 1X PBS, and 0.5% Tween-20 for 50 min. at room temperature. Fluorophore conjugated
Dylight 488 α-FLAG antibody (ThermoFisher Scientific) (2 µg/ml) was added to spheroplasts
and incubated at room temperature for 1 hr. Then spheroplasts were washed three times
with 1X PBS + 0.5% Tween-20 and resuspended in 1X PBS. DAPI dihydrochloride (Invitrogen)
(300 nM) was added and incubated with the spheroplasts for 10 min at room temperature.
Spheroplasts were washed five times with 1X PBS, then mounted onto a polylysine coated
slide with ProlongTM Diamond Antifade Mountant (Invitrogen). Prepared slides were be
visualized with an Olympus Fluoview FV3000 confocal microscope by Dr. Karan Kaval.
Immunofluorescence was also performed with yeast expressing FLAG tagged Nsr1, the most
abundant protein in the nucleolus of yeast cells (Ginisty et al., 1999) as a positive control and
with yeast transformed with an empty vector as a negative control.
2.8 Determination of Recombination and Mutation Rates
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Fluctuation analysis was performed as previously described (Kim and Jinks-Robertson,
2011). The SµG4-GTOP and SµG4-GBTM recombination reporter constructs are pictured in
Figure 5. Briefly, 12-36 individual 1-mL cultures of each strain were used for fluctuation
analyses and the recombination rates were calculated using the method of median as
described previously (Spell and Jinks-Robertson, 2004). Recombination rates are considered
significantly different if their 95% confidence intervals indicated with error bars do not
overlap. For fluctuation analysis of NSR1-deletion strains expressing different Nsr1 protein
constructs, cells were transformed with pADH1-Nterm Nsr1, pADH1-Cterm Nsr1, pADH1Nsr1, or pRS426 as a vector control. Twelve individual colonies per strain were used to
inoculate 1 mL cultures in synthetic complete media lacking uracil and containing 2% glucose
(SCD-Ura) and grown at 30°C. After 4 days, cultures were washed and diluted appropriately
and then plated on agar plates containing either SCD-Ura for determination of total CFU or
SCD-Ura/-Lys for determination of Lys+ recombinants. Recombination rates were determined
as described above. Where applicable, doxycycline hyclate (Sigma) was added to the growth
media to the concentration of 2 g/ml.
2.9 Top1-SUMO Pull Down
pGPD2-His-SMT3 was constructed by cloning the PCR-amplified His-SMT3 sequence
from the pYlplac211-ADH-His-SMT3 plasmid (a gift from Stefan Jentsch lab) into the pGPD2
vector (Addgene Cat# 43972) using BamH1 and Xma1 restriction sites. pGPD2-His-SMT3 was
transformed into wss1∆ strains harboring the indicated TOP1 alleles. Three to five colonies
from SCD-ura selection plates containing 2% glucose were used to inoculate 5 mL of SCD-ura
liquid media containing 2% glucose and were grown overnight at 30 °C. The next day, 2.5 mL
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of overnight culture was added to 50 mL SCD-ura liquid media containing 2% glucose and
cultures were grown at 30 °C shaking until they reached an OD 600 of ~1. Then, a total of 50
OD600 of cells were collected via centrifugation at 4°C and froze at -80 °C after washing twice
with H2O. The pull down of SUMO-conjugated proteins from whole cell lysates using HisPur
Ni-NTA Resin (Thermo Scientific; Cat# 88221) was performed as previously described (Ohkuni
et al., 2015). Input and pull down samples were resolved by SDS PAGE and transferred to
PVDF membrane with a Trans-BlotSD cell machine (Bio-Rad; Cat# 170-3940). Blots were
probed with an α-FLAG-HRP antibody (Sigma; Cat# A8592) and visualized by treatment with
ECL substrate (GenDEPOT; Cat# W3680-010) and a Bio-Rad ChemiDoc MP imaging system.
2.10 Co-Immunoprecipitation (co-IP) Experiments.
For each sample, 500 µL of saturated overnight culture was added to 50 mL of fresh
YPD media and grown shaking at 30 °C until they reached an OD600 of 1-1.5. A total of 44 OD600
of cells were collected by centrifugation at 4 °C and washed once in lysis buffer C (50 mM Tris
pH 8, 150 mM NaCl, and 7 mM EDTA) before pellets were frozen at -80 °C. Pellets were lysed
by the addition of 500 µL of lysis buffer D (lysis buffer C with 5 mM DTT, 1 mM PMSF, and
fungal protease inhibitor cocktail (Sigma; Cat# P8215) (50 µL/ 10 mL)) and acid washed glass
beads followed by 4 rounds of bead beating for 30 sec followed by 5 min of incubation on ice.
Next, lysates were clarified by centrifugation at 4 °C and 500 µL of lysis buffer D was added
to each sample. Fifty µL of equilibrated anti-Flag M2 Affinity Gel Beads (Sigma; Cat# A2220)
were added to each lysate and samples were incubated for 1 hr rotating at 4 °C. Anti-Flag M2
Affinity Gel Beads were then collected by centrifugation at 8,000 x g for 30 sec and washed 4
times. Each wash consisted of 1) centrifugation at 8,000 x g for 30 sec, 2) removal of

47

supernatant, 3) addition of 1 mL wash buffer E (lysis buffer D with 0.75% Triton X-100), and
then rotation at 4 °C for 25 min. After the last wash, beads were resuspended in 20 µL of lysis
buffer D. Proteins were eluted from the anti-Flag M2 Affinity Gel Beads by adding 20 µL of
200 µg/mL 3X-FLAG peptide (Sigma; Cat# F4799) and then incubating for 30 min at room
temperature while rotating. After elution, samples were centrifuged and 30 µL of supernatant
was collected and placed into a fresh 1.5 mL epitube. Fifteen µL of 4X SDS sample buffer was
added to the collected supernatants and samples were boiled for 10 min at 95 °C before being
resolved on a 4-20% SDS PAGE gel (Bio-Rad; Cat# 4561093) and subjected to western blotting.
Quantitative and statistical analyses of the co-IP were carried out as indicated for the oligo
pull-down procedure above.
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Chapter 3: Quantification of G4 Structures in Yeast in the Absence
of Top1
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3.1 Introduction to G4-Detection Methods
Non-B form DNA structures called G4s are known to form in certain repetitive DNA
sequences (Burge et al., 2006). Formation of G4s usually requires some amount of duplex
melting to allow for guanines to base pair with one another through Hoogsteen bonding.
Because of this, levels of helical torsion within DNA are thought to regulate G4-formation,
where increased levels of negatively supercoiled DNA yield conditions that favor the
formation of non-B DNA structures (Napierala et al., 2005; Sun and Hurley, 2009).
Transcription is an essential DNA transaction that generates negative helical stress, and thus,
non-B DNA structure formation is correlated with transcription levels (Wang and Vasquez,
2014). As mentioned in Chapter 1, yeast experiments demonstrated that the elevated
recombination observed at a model G4-capable motif (SµG4-GTOP) relative to a guanine-rich
motif not prone to G4-formation (SµG4-GBTM) is completely dependent on transcription
(SµG4 recombination reporters depicted in Figure 5) (Kim and Jinks-Robertson, 2011). This
suggests G4-formation does occur during transcription. Bioinformatics predicts there are >
1,400 G4-motifs present in the yeast genome (Todd et al., 2005), but it remains unknown how
many G4 structures stably form in yeast in vivo. Other data listed in Chapter 1 support that
activity of the enzyme Top1 modulates G4-formation during transcription by removing DNA
negative supercoils (Kim and Jinks-Robertson, 2011; Husain et al., 2016). These data allude to
the model where significantly more G4s form in highly-transcribed genomic loci in yeast cells
lacking Top1 than in normal cells. However, this postulate remains to be tested on a genomewide scale. Therefore, the goal of the work described in this chapter was to uncover if a
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greater number of G4s form in the yeast genome in the absence of Top1 by scoring stablyfolded G4s in vivo.
There are many different techniques used to detect G4-formation both in vitro and in
vivo. Gellert et al., 1962 first observed guanine tetrad formation in a gel-like substance
produced from cooling a high concentration guanosine solution (Gellert et al., 1962). X-ray
crystallography is a technique that solves 3D structures using diffraction patterns of X-rays
passed through crystals to map the electron density of molecules (Smyth and Martin, 2000).
When Gellert et al., 1962 used this technique to analyze the guanosine gel, a helical structure
containing 4 units per turn was revealed (Gellert et al., 1962). Since Jerry Donohue had
uncovered that 2 guanines can base-pair with each other, Gellert et al., 1962 proposed that
4 guanines interact to form planar guanine tetrads (Donohue, 1956; Gellert et al., 1962). Since
the discovery of the guanine tetrad, X-ray crystallography has been used to solve the 3D
structures of folded-G4s formed in G-rich oligos (Parkinson and Collie, 2019). Another in vitro
technique called circular dichroism (CD) is commonly used to discern the structural
conformations of G4-capable DNA oligo nucleotides (Kypr et al., 2009). In CD experiments, a
single wavelength of circularly polarized light is passed through a solution containing DNA
fragments that absorb different amounts of right circularly polarized light and left circularly
polarized light. Measuring the differential absorption of left and right circularly polarized
light, called molar ellipticity, across different wavelengths allows for the secondary structures
of nucleic acids to be inferred in solutions. For example, guanine-rich DNA oligos that form
parallel G4s exhibit CD spectrum results with a positive peak in molar ellipticity at 260 nm
and a negative peak at 240 nm (Balagurumoorthy et al., 1992). Another technique used to
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determine if guanine-rich DNA oligos adopt G4-conformations in vitro is the polymerase stop
assay (Weitzmann et al., 1996; Han et al., 1999). This method is based on the finding that
stable G4-structures block progression of polymerases during in vitro DNA synthesis
(Weitzmann et al., 1996). In polymerase stop assays, a primer labeled at it’s 5’-end is
annealed to a DNA template followed by the addition of a purified DNA polymerase enzyme.
After the primer-extension reaction has occurred, the 5’-end labeled extension products are
resolved on a urea-containing denaturing PAGE. If G4-forms in the DNA template strand, the
labeled primer will only be extended up to the G4-structure, resulting in detection of an
extension product that is smaller than the expected full-length extension product. G4formation in vitro can be further confirmed by performing CD and polymerase stop assay
experiments in the presence of K+ and Li+ ions, where K+ cations are known to support G4formation where Li+ cations are known to have a destabilizing effect on G4s (Konig et al.,
2010).
Like CD and polymerase stop assays, dimethyl sulfate (DMS) foot printing is another
method to detect G4-formation. DMS methylates the N7 atom of guanines in B-form DNA,
but in folded G4s, the N7 atom of guanines participate in Hoogsteen bonding and thus, are
protected from DMS methylation (Dabrowiak et al., 1997). Following DMS treatment of DNA,
piperidine is used to cleave the DNA at sites of methylated purines and cleavage products can
be analyzed by resolution on a 16% polyacrylamide denaturing gel to determine G4formation and -stability. Notably, while DMS footprinting can be done to probe in vitro G4formation of oligos and plasmids, it can also measure the in vivo formation of G4s at targeted
loci via ligation-mediated PCR, a method where a DNA linker with a known DNA sequence is
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annealed to the 5’ ends of target DNA fragments (Drouin et al., 2001). One study treated
human lung epithelial carcinoma cells with DMS to demonstrate in vivo G4-formation at the
VEGF promoter (Sun et al., 2011). Following DMS treatment, the cells were lysed and
extracted DNA was treated with piperidine. The genomic DNA cleavage products were then
subjected to ligation-mediated PCR, allowing for amplification of VEGF promoter specific DNA
fragments that were resolved by electrophoresis and analyzed. While in vivo DMS-foot
printing experiments have led to findings in the G4-field of study, like the aforementioned
validation of in vivo VEGF promoter G4-formation, this technique yields results that require
lengthy interpretation times. Further, in vivo DMS foot printing can only reasonably be used
to investigate individual genomic G4-loci rather than G4-formation on a genome-wide scale.
Therefore, newer in vivo methods of G4-detection have focused on analyzing global genomic
G4-formation in cells.
For the visualization of G4s in cells, fluorescent G4-probes have been developed
(Zhang et al., 2018; Chilka et al., 2019). One small molecular G4-probe called Napthotemplate-assembled synthetic G-quartet (N-TASQ) is both a smart fluorophore and G4binding ligand (Laguerre et al., 2014). In solution, the N-TASQ molecule exists in an “open
conformation”, where the molecule’s synthetic guanine attachments are extended outward
from the fluorescent-capable center of N-TASQ, preventing fluorescence (Laguerre et al.,
2016). Upon G4-binding, N-TASQ adopts a “closed conformation” where the synthetic planar
guanine tetrads of NTASQ undergo pi-stacking with the planar guanine tetrads of folded G4s.
In this closed conformation, the N-TASQ molecule is able to fluoresce. This G4-specific “lightup probe” has been used in multiple studies to show the in vivo formation of G4s in nuclei of
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different cell types including murine melanoma, human breast cancer, and human
osteosarcoma cells (Zhang et al., 2018). Notably, N-TASQ is also being pursued as a potential
diagnostic and site-specific therapeutic delivery tool in cancers or other diseases marked by
increased potential for G4-formation (Chilka et al., 2019).
In addition to small fluorescent G4-probes, G4-specific antibodies have been
developed to assess in vivo G4-formation as well. One of the first G4-specific antibodies,
Sty49, was used to visualize telomeric G4-formation in the macronuclei of the ciliated
protozoan Stylonychia lemnae (Schaffitzel et al., 2001). While these initial experiments
demonstrated that G4s do form in the chromosomes of organisms, the specificity of Sty49 to
the telomeric G4s of S. lemnae prevents its usage in investigating genome-wide G4-formation
in other species. Since the development of Sty49, G4 antibodies that bind more than just
telomeric G4s in specific organisms have been engineered. Currently, the most widely-used
G4-specific antibody is BG4 (Biffi et al., 2013), a monoclonal single-chain variable fragment
(ScFV) antibody where the variable region of an immunoglobulin heavy chain is fused to the
variable region of an immunoglobulin light chain via a short peptide linker (Huston et al.,
1988). BG4 was identified in a phage-display screen using a library of 2.3 × 1010 ScFV
antibodies (Schofield et al., 2007) aiming to find a G4-specific antibody that could interact
with a broad range of G4-structure types (Biffi et al., 2013). After BG4 was shown to interact
in vitro with a panel of intramolecular G4-oligos in a G4-selection screen, the BG4 coding
sequence was then cloned into the pSANG10 E. coli expression vector for antibody
purification. Enzyme-linked immunosorbent assays (ELISAs) conducted with G4-oligos
immobilized on a 96-well plate and purified BG4 revealed that BG4 binds intramolecular and
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intermolecular G4s, exhibiting Kds of 0.5-1.6 nm and ~2 nm, respectively. Importantly,
binding of BG4 to a duplex DNA oligo, a single-stranded DNA oligo, or an RNA hairpin was not
detected in ELISA experiments, demonstrating BG4 is highly specific for G4 DNA. Further
ELISA analyses revealed that BG4 is capable of high affinity interactions with G4s of different
structural conformations; i.e. parallel, anti-parallel, and hybrid G4s. Thus, it was concluded
that BG4 is a highly specific antibody that binds to a wide-range of G4 structures.
Since its discovery, BG4 has been used to visualize G4s in the nuclei of cells in
immunofluorescence experiments. Specifically, Biffi et al 2013 first used FLAG-tagged BG4
and a secondary fluorescent α-FLAG antibody to visualize G4-puncta in the nuclei of fixed
human osteosarcoma cells. It was confirmed that the puncta recognized by BG4 were G4DNA structures since incubation of the cancer cells with either G4-capable oligonucleotides
or DNase I abrogated the detection of nuclear BG4 foci. Quantitative BG4immunofluorescence of synchronized human mammary adenocarcinoma cells revealed that
G4s form in all phases of the cell cycle, with the most BG4-G4 foci visible in S-phase. Further
demonstrating that BG4-immunofluorencse can be quantitative, treatment of osteosarcoma
cells with the G4-stabilizing ligand pyridostatin (PDS) increased the number of BG4-G4 foci
present in nuclei by 2.9-fold.
While immunofluorescence experiments with BG4 have allowed for quantification of
G4s in cells treated with G4-stabilizing ligands and in differing cell cycle stages, these
experiments do not provide much detailed information about the locations of stably folded
G4s in the genome outside of well-studied genetic elements like telomeres (Biffi et al., 2013).
Multiple bioinformatic studies have mapped the locations of potential G4-forming sequences
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(PQS) or G4-motifs in genomes and uncovered G4-motifs are enriched in G-rich micro- and
mini-satellites, recombination hot spots, TSSs, promoters, telomeric DNA, and ribosomal DNA
(Todd et al., 2005; Marsico et al., 2019; Rawal et al., 2006; Eddy and Maizels, 2008). In the
human genome, one computational study estimated the presence of >375,000 G4-motifs
comprised of the sequence GGGN1-7GGGN1-7GGGN1-7GGG (Huppert and Balasubramanian,
2005). This study also uncovered that there are limited numbers of G4-motifs in exonic coding
strands, suggesting G4-formation is disfavored in RNA-forming DNA sequences in humans. A
separate bioinformatic study that took advantage of variations of next-generation
sequencing quality at unstable G4-capable loci found 736,689 G4-motifs in primary human B
lymphocytes (Tu et al., 2021). This higher number of > 700,000 G4-motifs relative to the ~
375,000 G4-motifs found in the previous study scanning the human genome for the GGGN 17GGGN1-7GGGN1-7GGG sequence, considered to be the canonical G4-motif (Davis and Maizels,

2011; Bochman et al., 2012), was the result of identification of non-canonical G4-motifs
containing long loops, bulges, and two tetrads. Around 90% of the G4-motifs identified in this
modified sequencing analysis method were confirmed to form G4s in vitro by G4-seq, a
method where next generation sequencing is performed after high-throughput polymerase
stop assays conducted with purified genomic DNA (Chambers et al., 2015). As mentioned
above, bioinformatics estimates 1,400 G4-motifs in the S. cerevisiae genome (Todd et al.,
2005) that are enriched in gene promoters (Capra et al., 2010). However, when G4-seq was
applied to S. cerevisiae, only 143 polymerase stalling G4-sites were identified (Marsico et al.,
2019).
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While the studies described above yielded useful results that expanded the definition
of G4-motifs, the bioinformatic information regarding locations of G4-motifs in genomes does
not prove in vivo G4-formation, especially since transcriptional state of chromatin affects the
ability of G-rich DNA sequences to convert to G4-conformations (Kim et al., 2011; Kim, 2019).
Therefore, ChIP-seq experiments conducted with G4-specific antibodies provided valuable
insights into the genomic locations where bona fide G4-formation occurs in cells. HänselHertsch et al., 2013 used purified FLAG-tagged BG4 in ChIP-seq experiments to show that
~10,000 G4s form in vivo in immortalized human keratinocytes. The locations of stably-folded
G4s overlapped with nucleosome-depleted genomic regions identified by next-generation
sequencing following formaldehyde-assisted

isolation

of

regulatory

elements,

demonstrating that in vivo G4-formation relies on an open chromatin state. G4s were also
enriched in promoters and 5’ UTRs of genes, especially in cancer-associated genes, in line
with other findings showing that G4s have roles in transcriptional regulation (reviewed in Kim,
2019). This work also provided two pieces of evidence supporting that G4-formation is
dependent on transcription. First, when cells were treated with the histone deacetylase
inhibitor entinostat, which leads to constitutive acetylation of histone H3K27 and thus
sustained transcriptional activity (Saito et al., 1999; Tomazou et al., 2015), ~ 4,000 intensified
or new BG4-ChIP-seq peaks were detected. Second, BG4 ChIP-seq experiments in nonimmortalized human keratinocytes showed ~ 10-fold less G4s relative to immortalized cells
with abnormally elevated transcriptional activity. In summary, Hänsel-Hertsch et al., 2013 not
only uncovered important information regarding in vivo G4-formation, but also showed that
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BG4 ChIP-seq can be used to quantify and compare the number of G4s that form in genomes
under different cellular conditions.
Based on previous results from Kim lab showing that TOP1-deletion enhances G4induced genomic instability (Kim and Jinks-Robertson, 2011; Yadav et al., 2014; Yadav et al.,
2016), I set out to quantify the number of G4s that form in the genomes of WT and top1∆
yeast cells through expression of the G4-specific antibody BG4 for immunofluorescence and
ChIP-seq experiments. I hypothesized that significantly more G4 structures would be able to
be detected in vivo in top1∆ yeast cells relative to WT yeast cells.
3.2 Results
3.2.1 Construction and Validation of Yeast BG4 Expression Plasmid.
I initially set out to use purified BG4 in immunofluorescence and ChIP experiments to
visualize and quantify the number of G4s present in yeast. However, my protein preps of Histagged BG4 expressed in and purified from Escherichia coli BL121 (DE3) cells yielded low
amounts of BG4 (Figure 6). Additionally, while my purification elutions did contain a ~ 30 Kda
protein that corresponds with the expected size of BG4, they also contained multiple other
contaminating proteins indicating that the BG4 protein purification protocol needs
optimization (Figure 6).
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Figure 6. BG4 antibody purified from E. coli. Coomassie stained SDS PAGE gel of His-tagged
BG4 purified from BL21 (DE3) E. coli cells using HisPur™ Ni-NTA Resin (ThermoFisher). M =
protein marker. FT = flow through. W = wash. * denotes location of BG4 band.
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Therefore, rather than using purified BG4, I tried out a new approach of BG4-G4
detection by expressing the BG4 antibody in yeast cells. To do this, I created a BG4 expression
plasmid called pGAL-BG4-FLAG. The pGAL-BG4-FLAG construct consists of the C-terminally
His- and FLAG-tagged BG4 protein under control of a galactose inducible promoter (pGAL) on
a 2µ yeast expression plasmid with a URA3 selectable marker (Figure 7). After plasmid
construction, I transformed yeast with pGAL-BG4-FLAG and showed that BG4 is expressed in
WT and top1∆ cells in the presence of galactose through western blotting (Figure 8). In order
to test whether overexpression of BG4 is toxic to cell growth in yeast, I performed a spot
assay to measure the survival of WT and top1∆ cells transformed with pGAL-BG4-FLAG or a
vector control on synthetic complete -URA (SCD-URA) plates containing either glucose or
galactose (Figure 9). I found that both WT and top1∆ cells transformed with pGAL-BG4-FLAG
grew as well as the cells with the vector control on plates containing galactose ranging in
concentrations from 0.01% to 2%. I also did not observe any differences in the survival of cells
transformed with pGAL-BG4-FLAG between the plates containing glucose where BG4
expression is suppressed and the plates containing galactose where BG4 expression is
induced.
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Figure 7. Schematic of pGAL-BG4-FLAG vector for expression of BG4 in yeast.
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Figure 8. BG4-FLAG antibody construct is expressed from the pGAL-BG4-FLAG vector in
yeast. Western blot of lysates prepared from WT and top1∆ cells transformed with control
and pGAL-BG4-FLAG vectors. Blots were probed with an α-FLAG antibody to detect BG4 or an
α-GAPDH antibody for a loading control. C = purified BG4 (size control). V = vector control.
BG4 = pGAL-BG4-FLAG.
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Figure 9. Expression of BG4 does not affect survival of yeast. Survival assays of yeast cells
transformed with pGAL-BG4-FLAG (pGal-BG4) or vector control (Vec) in media with different
carbon sources. Cells were diluted 1:10 serially before spotting on plates. Images shown were
taken 3 days after growth at 30 °C. A. Survival of WT cells. B. Survival of top1∆ cells.
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Next, in order to verify if expressed BG4 was functional and able to bind to G4
structures, I performed an in vitro oligo binding assay. First, either biotinylated G4-capable
oligonucleotides (oligos) (SµG and BRCA-G1) or biotinylated non-G4 control oligos (SµC and
ssDNA) conjugated to streptavidin magnetic beads were incubated with yeast whole cell
extracts prepared from cells transformed with pGAL-BG4-FLAG (Figure 10A). After pull down
of the magnetic beads, western blotting of pull down samples revealed that BG4 bound the
SµG and BRCA1-G1 G4 oligos but not the M1 control oligo (Figure 10B), demonstrating that
the BG4 construct expressed in yeast cells is functional and G4-specific.
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Figure 10. BG4 expressed in yeast binds G4s in vitro. A. Table of oligos used in biotin oligo
pull down in Figure 10B. SµG and BRCA-G1 oligos form G4s while SµC and ssDNA do not.
Guanines that participate in G4-formation are in bold, underlined, and italicized. B. Western
blot from biotinylated oligo pull down assay performed with streptavidin magnetic beads and
yeast whole cell lysates expressing BG4-FLAG from pGAL-BG4-FLAG or the vector control.
Blots were probed with an α-FLAG-HRP (Sigma) antibody.
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3.2.2 Measuring Expressed BG4-G4 Structure Binding in vivo.
Next, in order to determine the number and locations of G4s that form in the yeast
genome, I aimed to perform chromatin immunoprecipitation followed by next generation
sequencing (ChIP-seq) in WT and top1∆ cells transformed with pGal-BG4-FLAG. I expected to
observe a higher number of BG4-FLAG enrichment peak locations in cells lacking Top1
compared to WT cells throughout the yeast genome. Additionally, I expected to uncover a
positive correlation between stably-folded in vivo G4s and highly transcribed genes, where
lowly transcribed genes harboring G4-motifs would exhibit less in vivo G4-formation than
highly transcribed genes with G4-motifs.
Before performing ChIP-seq in cells transformed with pGAL-BG4-FLAG, I first wanted
to validate that BG4 is enriched at the model G4-forming SµG4-GTOP locus in top1∆ cells.
Thus, I transformed top1∆ yeast cells containing the SµG4-GTOP reporter with either pGALBG4-FLAG or the vector control, and performed ChIP-qPCR using primers that target the SµG4
locus and a negative control CAN1 locus. I expected to observe increased fold enrichment (G4
enrichment/ CAN1 enrichment) of BG4 at the SµG4-GTOP locus compared to vector control,
which would indicate BG4-G4 DNA in vivo binding. However, ChIP-qPCR results did not show
increased enrichment of BG4 at the G4 locus relative to the vector control (Figure 11).
Therefore, I did not move on to perform BG4 ChIP-seq with the expressed pGAL-BG4-FLAG
construct.
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Figure 11. Fold enrichment of BG4 at SµG4 G4 locus relative to the non-G4 capable CAN1
locus in vivo. Averages and standard deviations of BG4 and vector control fold enrichments
at G4 locus in a top1∆ GTOP background (n=2).
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3.2.3 Visualizing G4 Structures in Yeast in vivo.
As an alternate approach to quantify the number of G4 structures that form in WT
and top1∆ yeast cells, I performed immunofluorescence experiments with yeast cells
transformed with either pGal-BG4-FLAG or the vector control. With the help of Dr. Karan
Kaval in the Garsin lab at UTHealth, a GFP-conjugated α-FLAG antibody (Dylight 488 α-FLAG
antibody; ThermoFisher Scientific) was used to detect α-FLAG/BG4 foci in top1∆ cells. We
expected to detect multiple α-FLAG/BG4 foci within the DAPI-stained nuclei of cells
expressing pGal-BG4-FLAG (expected immunofluorescence results are depicted in Figure 12).
However, we were not able to detect α-FLAG/BG4 foci within the nuclei of pGAL-BG4
transformed cells (Figure 13). In fact, the pGal-BG4-FLAG cells did not look different from the
negative control cells transformed with the empty vector, where no green foci were expected
to be visualized (Figures 13 and 14). In both pGal-BG4-FLAG- and vector control-transformed
cells, there were high levels of green fluorescent background signal (Figures 13C and 14C),
indicating that my immunofluorescence protocol needs to be optimized to reduce
background signal. Further, some cells in both pGAL-BG4-FLAG- and vector controltransformed samples seemed to have α-FLAG puncta localized to the outside of the cell
(Figures 13C and 14C), suggesting that the α-FLAG antibody may not be efficiently getting into
the cells and that cell permeabilization conditions should be optimized.
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Figure 12. Expected immunofluorescence microscopy results of yeast cells expressing pGALBG4-FLAG, the vector control, or Nsr1-FLAG (positive control).
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Figure 13. Immunofluorescence microscopy of top1∆ yeast cells expressing pGAL-BG43XFLAG. Slides were prepared by Alexandra Berroyer and were imaged by Dr. Karan Kaval with
an Olympus Fluoview FV3000 confocal microscope. All scale bars are 5 µm. A. Differential
interference contrast (DIC) image. B. DAPI stain fluorescent image. C. Image of cells stained
with an α-FLAG Dylight 488 antibody (ThermoFisher). D. Merge of B. and C. E. Zoom in on
yeast cell from A and D.
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Figure 14. Immunofluorescence microscopy of top1∆ yeast cells expressing the vector
control. Slides were prepared by Alexandra Berroyer and were imaged by Dr. Karan Kaval
with an Olympus Fluoview FV3000 confocal microscope. All scale bars are 5 µm. A.
Differential interference contrast (DIC) image. B. DAPI stain fluorescent image. C. Image of
cells stained with an α-FLAG Dylight 488 antibody (ThermoFisher). D. Merge of B. and C. E.
Zoom in on yeast cell from A and D.
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To further check my immunofluorescence staining technique, I performed the
protocol with positive control yeast cells that expressed a FLAG-tagged version of the
nucleolar protein Nsr1 (Figure 15) (Ginisty et al., 1999). The yeast nucleolus occupies around
one-third of the total volume of the nucleus and is visualized as a crescent shaped structure
(Aris and Blobel, 1988; Matos-Perdomo and Machin, 2019). Thus, we expected to see
colocalization of a crescent-shaped Nsr1-FLAG focus within the DAPI stained nucleus (Figure
12). However, except for one cell denoted by an arrow in Figure 15D, we did not observe
colocalization of Nsr1-FLAG with DAPI and the background associated with the fluorescent
FLAG antibody was very high. Overall, I concluded my immunofluorescence protocol needs
to be modified to reduce background fluorescence, improve cell permeability, and increase
antibody specificity.
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Figure 15. Immunofluorescence microscopy of yeast cells expressing FLAG-tagged Nsr1.
Slides were prepared by Alexandra Berroyer and were imaged by Dr. Karan Kaval with an
Olympus Fluoview FV3000 confocal microscope. All scale bars are 5 µm. A. Differential
interference contrast (DIC) image. B. DAPI stain fluorescent image. C. Image of cells stained
with α-FLAG Dylight 488 antibody (ThermoFisher). D. Merge of B. and C. Arrow denotes cell
exhibiting DAPI and Nsr1-3XFLAG colocalization. E. Zoom in on cell denoted by arrow in C.
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3.3 Discussion
Helical torsion in DNA causes complications during cellular DNA transactions (GomezGonzalez and Aguilera, 2019). One source of torsional stress is transcription, which yields
positively supercoiled DNA and negatively supercoiled DNA located in front of and behind
RNA polymerase 2, respectively (Ma and Wang, 2014; Ma and Wang, 2016; Kim and JinksRobertson, 2017). While normal, unstressed DNA contains ~ 10.5 bp per turn, positively
supercoiled DNA is overwound and contains < 10.5 bp per turn and negatively supercoiled
DNA is underwound and contains > 10.5 bp per turn. Both positively and negatively
supercoiled DNA are problematic for cells. Extreme levels of positive supercoils can block the
progression of RNA polymerase during transcription, resulting in genomic instability and
accumulation of truncated messenger RNA molecules. Conversely, the accumulation of
negative supercoils during transcription is deleterious because it leads to the formation of
single-stranded patches in DNA and mutagenic R-loop formation. Single-stranded DNA, in
either an R-loop or in a portion of melted duplex DNA, is more prone to DNA damage and
base modification than duplex DNA (Lindahl, 1993; Beletskii and Bhagwat, 1996; Kim and
Jinks-Robertson, 2012; Hamperl and Cimprich, 2014). Further, the formation of replicationblocking non-B DNA structures, like G4s, usually requires for duplex melting to occur which
can favor DNA base interactions within a single strand of DNA (Sun and Hurley, 2009).
G4s normally form in single-stranded DNA sequences containing a GGGN1-7GGGN17GGGN1-7GGGN1-7 motif when guanines interact with one another through Hoogsteen
bonding (Bochman et al., 2012; Burge et al., 2006). G4-formation happens during
transcription and is linked to negatively supercoiled DNA (Sun and Hurley, 2009; Kim, 2019).

77

Top1 removes transcription-associated negative supercoils from DNA, and the genomic
instability induced by multiple non-B DNA structures, including G4s, is repressed by Top1
functioning (Drolet, 2006; Kim and Jinks-Robertson, 2011; Hubert et al., 2011; Yadav et al.,
2014; Yadav et al., 2016). This supports a model where Top1 suppresses G4-induced genomic
instability in cells by preventing the accumulation of transcriptionally derived negative
supercoils and consequential formation of G4s. Here, I set out to test this model by two
approaches: ChIP-seq and immunofluorescence with the G4-specific antibody BG4.
Hänsel-Hertsch et al., 2016 successfully used BG4-ChIP-seq to quantify the number of
G4s in the genomes of immortalized and non-immortalized human keratinocytes (HänselHertsch et al., 2016). While purified BG4-FLAG was used for their experiments, I tried to
perform ChIP experiments by expressing BG4-FLAG in yeast from the pGAL-BG4-FLAG vector
as a novel approach (Figure 7). Although my BG4-FLAG construct expressed from pGAL-BG4FLAG was able to bind G4s in vitro (Figure 10), I did not detect enrichment of BG4-FLAG at the
G4 locus compared to a vector control in a TOP1-deletion background via ChIP-qPCR (Figure
11). This indicates that expressed BG4 was not able to bind to G4s in vivo and that further
work needs to be done to enable the usage of expressed BG4 in the genome-wide
quantification of G4s in yeast. One potential reason expressed BG4 was not enriched at SµG4GTOP could be that the BG4 construct does not contain a nuclear localization sequence. Since
the import of most proteins into the nucleus is mediated via importin proteins that recognize
nuclear localization sequences (Mattaj and Englmeier, 1998), it is possible that expressed BG4
is only localized to the cytoplasm of yeast cells. Continuous cytoplasmic localization would
prevent expressed BG4-FLAG from binding G4 DNAs in the nucleus. Therefore, a nuclear
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localization amino acid signal sequence, such as the widely used SV40 large T-antigen nuclear
localization signal sequence (CTPPKKKRKV) (Kalderon et al., 1984), should be fused to the
BG4-FLAG amino acid sequence in pGAL-BG4-FLAG. Alternatively, ChIP-seq experiments
could be performed with purified BG4 antibody as was done in Hänsel-Hertsch et al., 2016.
In fact, purified BG4-FLAG has recently become commercially available from Millipore Sigma
(Catalog # MABE917), bypassing the requirement to purify BG4 from E. coli myself. Besides
usage of BG4, ChIP-seq experiments could be performed with other yeast G4-binding
proteins, like Sub1 or Nsr1, that have been shown to be enriched at the G4 locus significantly
more than at a non-G4 capable control locus in vivo via ChIP-qPCR (Lopez et al., 2017; Singh
et al., 2020).
Although I didn’t see any increased enrichment of expressed BG4 at the model G4
locus relative to the vector control in top1∆ in ChIP-qPCR experiments, I still tried performing
immunofluorescence in top1∆ cells transformed with pGAL-BG4-FLAG. I reasoned that
visualizing the localization of our expressed BG4 construct within top1 yeast cells may provide
information that could be used to modify and improve ChIP-qPCR experiments. However, I
did not observe any BG4-foci in the nuclei of the top1∆ cells transformed with pGAL-BG4FLAG. One issue with the immunofluorescence experiments performed was that a high
amount of background green fluorescence was present in cells stained with the GFPconjugated α-FLAG antibody (Figures 13 and 14). In the future, the green fluorescent
background should be reduced by increased blocking time and more extensive washing as
well as treatment with different antibody dilutions to find an optimal antibody concentration.
Another issue was that α-FLAG puncta seemed to be localized outside of some cells (Figures
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13 and 14). This indicates that the Dylight 488 α-FLAG antibody may not be getting into all
cells efficiently, and binding of the fluorescent antibody outside of cells may also explain the
high levels of background fluorescence observed. The problem with permeability of the αFLAG antibody was also apparent in immunofluorescence experiments using the Nsr1-FLAG
positive control depicted in Figures 15D and 15E, where only one cell seemed to exhibit
colocalization of Nsr1 with the yeast nucleus. In the future, this protocol should be optimized
and different permeabilization conditions should be tested such as treatment with different
detergent concentrations and treatment times, and usage of various detergents altogether
to try and increase the entrance of antibody into cells. Also, the spheroplasting protocol
should be improved to find an optimum condition that makes the yeast cell wall more
permeable. Since the expressed BG4 construct does not harbor a nuclear localization signal
sequence, it is unclear if expressed BG4 is localized in the cytoplasm only or if it also enters
the nucleus. Thus, either adding a nuclear localization signal sequence to the expressed BG4
construct or performing the immunofluorescence experiments with purified BG4 added to
yeast cells after crosslinking and permeabilization could significantly improve the
visualization of G4s in the yeast nucleus. Further, small molecules that fluoresce upon G4binding, such as NaphthoTASQ, have been used to visualize G4s via microscopy in human cells
(Laguerre et al., 2016). These small fluorescent G4-binding ligands may enter the yeast cell
more readily that an antibody, making them an attractive alternative to immunofluorescence
in the visualization of G4s. Additionally it could be that the small size of the yeast nucleus (~
2 µm in diameter) makes visualizing G4s in cells technically challenging (Taddei and Gasser,
2012). Therefore, chromosome spreading may be a better approach to visualize G4s that
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form

in

the

yeast

genome.

Chromosome

spreading

is

a

technique

where

whole chromosomes are extracted from cells and are spread on a glass microscope slide
(Rockmill, 2009). Once spread on the slide, the yeast chromosomes could be stained with
BG4-FLAG or a fluorescent G4 ligand. In fact, chromosome spreading coupled with
immunofluorescence was used to visualize R-loops in yeast chromosomes (LafuenteBarquero et al., 2017).
In conclusion, I was not able to quantify the number of G4s in the yeast genome in
vivo by either ChIP-seq or immunofluorescence approaches performed with my BG4
construct expressed from pGAL-BG4-FLAG. Future approaches should include either a
modified form of the expressed BG4 construct containing a nuclear localization signal
sequence, purified BG4, other yeast G4-binding proteins, or small fluorescent G4 ligands.
Also, the experimental approach called DMS footprinting mentioned in section 3.1 could be
employed to measure G4-formation/stability in vivo in WT and top1∆ cells at specific G4capable genomic loci. If TOP1-deletion results in an increase of G4-formation at SµG4-GTOP
in vivo, then more DMS protection would be observed in SµG4-GTOP DNA isolated from
top1∆ cells than in SµG4-GTOP DNA isolated from WT cells.
Determining if the absence of Top1 significantly affects the extent of G4 DNA
formations in vivo is clinically relevant given the contribution of G4s to the development and
progression of diseases like cancer (Bacolla et al., 2016; Bacolla et al., 2019). Additionally,
Top1 is a major cancer chemotherapeutic target and is frequently mutated or present at
reduced levels in cancer cells as a consequence of treatment (Beretta et al., 2013). Therefore,
understanding how lack of functional Top1 impacts G4-formation on a genome-wide scale

81

could be relevant to the development of novel therapeutic strategies for cancer patients
displaying resistance to Top1-targeting anticancer drugs.

82

Chapter 4: Cleavage-Defective Topoisomerase I Mutants Sharply
Increase G-quadruplex-Associated Genomic Instability

Note: Portions of this chapter were derived from a manuscript accepted for publication in
Microbial Cell. BERROYER, A., BACOLLA, A., TAINER, J. A., and KIM N. 2022. Cleavage-defective
Topoisomerase I mutants sharply increase G-quadruplex-associated genomic instability.
Microbial Cell, Accepted January 19th 2022. microbialcell.com is the property of the Shared
Science Publishers OG. Unless otherwise stated, all articles and corresponding materials
accompanying them that are published by Shared Science Publishers OG on this Web Site are
licensed by their respective authors for your use and distribution provided you cite the original
source as specified in the corresponding Creative Commons Attribution License. Creative
Commons Attribution License weblink: https://creativecommons.org/licenses/by/4.0/.
Article available at http://microbialcell.com/researcharticles/2022a-berroyer-microbial-cell/.

83

4.1 Introduction to Top1 Mutants
Top1 is an enzyme that relieves helical stress in DNA accumulated during
transcription. Top1 binds duplex DNA, nicking one-strand of DNA with a catalytic tyrosine
residue, and re-ligates the nick in DNA after controlled strand swiveling (Stewart et al., 1998).
The complete deletion of the Top1-encoding gene in yeast or the siRNA-mediated knockdown
of Top1 in mouse lymphoma B-cells results in highly elevated instability at genomic loci
containing actively transcribed G4 DNA-forming sequences (Kim and Jinks-Robertson, 2011;
Yadav et al., 2014; Husain et al., 2016). Further examination in yeast demonstrated that
removal of transcription-associated negative excess helical tension by Top1 suppresses G4induced recombination at these loci, indicating that Top1 plays an important role in
protecting the genome by preventing G4-formation (Yadav et al., 2016). Top1 is a clinically
relevant enzyme; it is the sole target of widely used anti-cancer chemotherapeutic
camptothecin (CPT) and its derivatives including irinotecan and topotecan (Pommier et al.,
2010). CPT targets Top1 by stabilizing the Top1-cleavage complex (Top1cc) consisting of Top1
covalently attached to the 3´ end of a DNA nick and then by preventing the re-ligation step.
To repair Top1ccs trapped by either DNA lesions or Top1 inhibitors including CPT, singlestrand break repair TDP1 in complex with ligase III and XRCC1 can remove 3'-tyrosine residues
remaining after degradation of Top1 (Rashid et al., 2021). Therefore, CPT cytotoxicity is
mainly dependent on nuclear influx of CPT and DNA cleavage by Top1. While there are
multiple ways in which cancer cells can become resistant to CPT, a prevalent mechanism of
resistance is the mutation of Top1 such that the enzyme can no longer bind or cleave DNA. In
fact, mutations that reduce Top1 DNA binding and/or cleavage are documented in cancer
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patients and cells treated with CPT or CPT-derivatives (Beretta et al., 2013). Whether these
Top1 mutants that arise in cancer cells in response to CPT-treatment affect G4-induced
genomic instability has not been examined.
Interestingly, Top1 itself can bind tightly to G4 structures and can even promote
formation of intermolecular G4s in vitro (Arimondo, 2000; Marchand et al., 2002). The yeast
Top1 catalytic mutant Y727F, which can bind but not cleave duplex DNA, also binds to G4
DNA-forming oligos in vitro (Berroyer and Kim, 2020). Expression of Top1Y727F in yeast
results in extremely elevated instability at a model G4-motif that is significantly higher than
top1 null mutation, possibly resulting from the high-affinity binding of Top1Y727F to cotranscriptionally formed G4s in vivo (Yadav et al., 2016). Here, Nayun and I investigated how
CPT-resistance conferring Top1 mutants, like yTop1Y727F and those found in cancers, affect
G4-induced genomic instability in S. cerevisiae.
In addition to yTop1Y727F, I constructed two other yeast strains with TOP1 mutant
alleles (Table 4). yTop1Y740Stop is analogous to the human Top1W763Stop mutant identified
in a lung cancer patient treated with the CPT-derivative irinotecan and is predicted to have
reduced catalytic activity, while yTop1S733E is a duplex DNA binding mutant analogous to
human Top1T729E mutant that confers CPT-resistance when expressed in yeast (Tsurutani et
al., 2002; Losasso et al., 2008). Construction of both the yTOP1Y740STOP and yTOP1S733E
strains allowed for me to distinguish between Top1 DNA cleavage-defects and Top1 DNA
binding-defects as causes of G4-associated genomic instability. Expression of all C-terminally
3XFLAG-tagged Top1 mutants enabled their detection by western blotting (Figure 16A and
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B). yTop1Y740Stop yielded a significantly lower steady-state protein level than WT yTop1,
yTop1Y727F, or yTop1S733E.
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Table 4. Top1 mutants studied
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Figure 16. Yeast homologs of human Top1 mutants found in cancer cells are expressed. A.
Western blot of cell extracts prepared from yeast strains expressing FLAG-tagged Top1
proteins. Blots were probed with α-FLAG-HRP (Sigma) and α-GAPDH-HRP (Invitrogen)
antibodies. B. Quantification of Top1 mutant protein levels. Means and standard deviations
of Top1 pixel intensities normalized to Gapdh pixel intensities from 5 western blots performed
as in A. Significance of statistical differences was determined by Student T-tests (GraphPad
Prism).
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In order to confirm that the newly constructed yeast Top1 mutants Y740Stop and
S733E are functionally defective, as expected from the study of analogous human mutations,
I performed a spot assay using plates that contained CPT. Of note, I used MUS81-deletion
yeast strains to perform the CPT spot assay so the repair of Top1ccs would be partly disabled.
While the yeast strain expressing WT Top1 showed sensitivity to 5 µM and 20 µM CPT,
yTOP1Y740Stop and yTOP1S733E strains were resistant to CPT like the top1∆ yeast strain
(Figure 17). To further confirm the yeast Top1 mutants are catalytically dead, Nayun and I
used a yeast genetic assay where four AG repeats were inserted into the reversion window
of the lys2∆A746,NR frameshift allele (Cho et al., 2013; Cho et al., 2015). As reported earlier,
the reversion mutation at lys2∆A746,NR,(AG)4 allele, which requires a net of two base pair
deletion, is dependent upon the presence of functional Top1, particularly when RNase H2 is
absent. The RNase H2 complex normally keeps genomic DNA free of ribonucleotides by
initiating the excision repair of ribonucleotides incorporated during replication. In rnh201∆
backgrounds, ribonucleotides remaining embedded in DNA are subsequently cleaved by Top1
and, in the case of repetitive sequences, frequently lead to slippage or frameshift mutations.
For the lys2∆A746,NR,(AG)4 allele, processing of the Top1-nicked DNA ends leads to two base
pair deletions within the (AG)4 repeats (Cho et al., 2013; Cho et al., 2015). As reported earlier,
absence of functional Top1, as in top1∆ backgrounds, results in >200-fold decrease in the
mutation rate at the lys2∆A746,NR,(AG)4 allele (Cho et al., 2013) (Table 5). Since mutagenic
processing of ribonucleoside monophosphates (rNMPs) is dependent on Top1’s ability to
cleave DNA, we expressed Top1 mutants in the lys2∆A746,NR,(AG)4 rnh201∆ background to
measure Top1-dependent rNMP cleavage as a proxy for Top1 catalytic activity. LYS2 reversion
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mutation rates of the yTOP1Y727F, yTOP1Y740Stop, and yTOP1S733E lys2∆A746,NR,(AG)4
rnh201∆ were all statistically indistinguishable from the top1∆ lys2∆A746,NR,(AG)4 rnh201∆
rate, confirming all three of the yeast Top1 mutants are catalytically inactive (Table 5).
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Figure 17. Yeast Top1 mutants Y740Stop and S733E are resistant to CPT. Spot assays of
MUS81-deletion yeast cells on control plates (YPD and DMSO) or plates containing the
indicated concentrations of CPT. Cells were diluted 1:10 serially before spotting on plates.
Images shown were taken 2 days after growth at 30 °C.
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Table 5. Catalytic activity of Top1 mutants determined by measuring the Lys+ mutation rate
of yeast strains harboring a pTET-lys2-AG4 reporter. Rates are considered statistically
significantly different if their 95% confidence intervals do not overlap (Spell & JinksRobertson, 2004). CI = 95% confidence interval. Yeast strains for this experiment were
constructed by Alexandra Berroyer and mutation rates were measured by Dr. Nayun Kim.
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I next measured the ability of the Top1 mutants to bind to a duplex DNA oligo using
an in vitro biotinylated oligonucleotide (oligo) pulldown assay. The biotinylated SS oligo was
annealed to the non-biotinylated RC-SS oligo to create a duplex substrate that could be used
to pull down the Top1 mutants from yeast whole cell lysates if binding occurs (Figure 18A).
As expected, the yTop1Y727F and yTop1Y740Stop cleavage-defective mutants bound duplex
DNA while the yTop1S733E DNA binding-defective mutant did not (Figure 18B). These DNA
binding results coupled with the lys2∆A746,NR,(AG)4 allele reversion mutation analysis
results listed above validate the phenotypes of all three yeast Top1 mutants listed in Table 4.

93

Figure 18. Top1 catalytic mutants bind duplex DNA substrates in vivo, while Top1 DNA
binding mutants do not. A. Sequences of oligonucleotides (oligos) used in in vitro binding
oligo binding assay shown in B. B. Western blot of in vitro binding assay utilizing biotinylated
oligos conjugated to streptavidin magnetic beads and yeast whole cell lysates prepared from
cells expressing FLAG-tagged Top1 proteins. Blot was probed with an α-FLAG-HRP (Sigma)
antibody. SS = biotinylated single-stranded oligo control. DS = SS biotinylated oligo annealed
to non-biotinylated RC oligo to create a duplex substrate. Quantification of binding is below
blot and was calculated by dividing Input pixel intensities from Pull down pixel intensities.
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4.2 Results
4.2.1 Cleavage-Defective Top1 Mutants Bind G4s in vitro.
WT human Top1 binds to G4-forming oligos with high-affinity in vitro (Arimondo,
2000; Marchand et al., 2002). For the yeast protein, I previously showed that WT yTop1 and
yTop1Y727F can bind G4 DNA in vitro (Berroyer and Kim, 2020). Enrichment of yTop1 and
yTop1Y727F at a G4-capable telomeric region in yeast was also shown by ChIP experiments.
To further examine G4-binding of WT yTop1 and yTop1Y727F and to determine if
yTop1Y740Stop and yTop1S733E interact with G4s, I performed in vitro DNA binding assays
using an oligo that is G4-capable (SµG) (Table 6). As a non-G4 control, I used M1, where two
guanine-runs present in SµG were interrupted. WT yTop1, yTop1Y727F, and yTop1Y740Stop
all formed stable complexes with the SµG oligo (Figure 19A). However, yTop1S733E lacked
appreciable binding to SµG oligo, indicating that Top1 duplex DNA binding mutants do not
form stable complexes with G4 structures like WT yTop1 or the Top1 cleavage-defective
mutants yTop1Y727F and yTop1Y740Stop. Interestingly, while quantification revealed that
yTop1Y740Stop bound the SµG oligo significantly better than WT yTop1 or yTop1Y727F
(Figure 19B), none of theTop1 proteins tested bound the G4-incapable M1 oligo, indicating
that WT yTop1 and Top1 cleavage-defective mutants possess G4 structure-specificity in this
assay (Figure 19A and B).
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Table 6. Oligonucleotides used in binding assays. SµG oligo can adopt a G4 conformation
while the M1 oligos cannot. Guanine-runs in SµG oligo are in bold. G>A mutations in M1 oligo
introduced to disrupt guanine-runs are indicated as lower case letters. *G-score was
calculated using QGRS Mapper (https://bioinformatics.ramapo.edu/QGRS/index.php;
parameters: Max Length – 44, Min G-Group Size – 3, and Loop Size – 0 to 10).
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Figure 19. Top1 mutants bind G4 oligos in vitro and increase G4-induced recombination in
yeast. A. Western blot from biotinylated oligo pulldown assay performed with streptavidin
magnetic beads and yeast whole cell lysates expressing FLAG-tagged Top1 proteins. Blot was
probed with an α-FLAG-HRP (Sigma) antibody. Quantification of binding is listed below blot
and was calculated by dividing input pixel intensities from pull down pixel intensities. B.
Quantification (means and standard deviations of pull-down pixel intensities normalized to
input pixel intensities) of western blots from 3 in vitro biotin oligo pulldown assays with SµG
and M1 oligos and Top1 proteins performed as in A. Vertical error bars only show positive
standard deviations. P-value derived from students T-test (GraphPad Prism). C. Transcription
orientations and the guanine-runs in the Sµ-containing recombination reporter constructs.
Guanine-runs are located on the non-transcribed or the transcribed strand in the pTET-lys2GTOP or pTET-lys2-GBTM construct, respectively. The red line within the transcription bubble
indicates the transcript. RNA polymerase complex is indicated as blue oval in front of the
transcription bubble. D. Recombination rates of Top1 mutant-expressing yeast strains. Rates
are considered statistically significantly different if their 95% confidence intervals (shown as
error bars) do not overlap (Spell and Jinks-Robertson, 2004).
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4.2.2 Top1 Cleavage-Defective Mutants Increase G4-Induced Recombination More Than a
Top1 Duplex DNA Binding Mutant.
I examined the effect of transcription on G4-induced recombination using a reporter
construct containing a model G4-motif from the mouse immunoglobulin switch region Mu
(SµG4). In this reporter, a segment of SµG4 was integrated into the yeast genome within the
LYS2 gene under the control of tetracycline/doxycycline-repressible promoter (pTET-lys2)
(Kim and Jinks-Robertson, 2011). The SµG4-motif was inserted into the pTET-lys2 allele in two
different transcriptional orientations, each disrupting the LYS2 ORF. In GTOP orientation
(pTET-lys2-GTOP), the guanine runs of SµG4 are on the non-transcribed strand (NTS) which is
transiently single-stranded during transcription, facilitating G4-formation (Figure 19C). In
GBTM orientation (pTET-lys2-GBTM), the guanines of SµG4 are on the transcribed strand (TS),
which is based paired with the nascent mRNA during transcription and thus not likely to adopt
G4-conformations. In this reporter assay, DNA strand breaks at SµG4 GTOP or GTBM are
repaired via recombination utilizing a truncated genomic copy of LYS2. The recombination
rate at SµG4 can thus be inferred from the emergence of Lys+ recombinants. Any factor that
affects G4-formation or -stability involves recombination starting at GTOP, but not GBTM
(Kim and Jinks-Robertson, 2011). The Kim lab has previously shown that more recombination
occurs at pTET-lys2-GTOP than at -GBTM under active transcription, and that this difference
in recombination is increased significantly by the absence of Top1, supporting the hypothesis
that Top1 functions to prevent co-transcriptional G4-formation by averting excessive
torsional stress on DNA (Yadav et al., 2016).
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Using the pTET-lys2-GTOP and -GBTM reporter strains, I first confirmed that the Cterminal 3X-FLAG tag does not affect the functioning of WT yTop1 in a recombination
reporter assay (Figure 20). For yeast strains expressing yTop1Y727F or yTop1Y740Stop
mutants, the recombination rates for the pTET-lys2-GTOP reporter construct were ~ 3.8- or ~
4.9-fold higher than the rate for top1Δ strain, respectively (Figure 19D). The pTET-lys2-GTOP
recombination rate in yTop1S733E-expressing strain was significantly lower than for the
yTop1Y727F- or yTop1Y740Stop-expressing mutants and was statistically similar to the top1Δ
strain. These results indicate that the exacerbated genomic instability at G4s in yeast cells
expressing the Top1 cleavage-defective mutants yTop1Y727F or yTop1Y740Stop is due to a
mechanism distinctly different from the top1∆ or the DNA binding-defective mutant
yTop1S733E-expressing cells. Importantly, the effect of Top1 mutation on recombination is
G4-specific since the recombination rates at the pTET-lys2 GBTM reporter construct did not
significantly change by the expression of any of the Top1 mutants (Figure 19D). When
transcription through SµG4 was suppressed by adding doxycycline to culture media, the pTETlys2-GTOP recombination rates of the top1∆, yTOP1Y727F, yTOP1Y740Stop, and yTOP1S733E
strains were slightly elevated relative to the WT GTOP rate but to much less extant than
without doxycycline (Figure 21). Thus, the effect of TOP1-deletion and mutation on GTOP
recombination is largely transcription-dependent.
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Figure 20. C-terminal 3X-FLAG tag does not impact the function of WT yTop1.
Recombination rates of WT yTop1 tagged and untagged recombination reporter strains.
GTOP indicates recombination at G4-motif while GBTM indicates recombination at a loci not
prone for G4-formation. Rates are considered statistically significantly different if their 95%
confidence intervals (shown as error bars) do not overlap (Spell & Jinks-Robertson, 2004).
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Figure 21. The effect of transcriptional repression on the GTOP and GBTM recombination
rates of Top1 mutant strains. Doxycycline was added to the media of fluctuation cultures to
repress transcription from the pTET promoter upstream of the SµG4 GTOP and GBTM
constructs. Rates are considered statistically significantly different if their 95% confidence
intervals (shown as error bars) do not overlap (Spell & Jinks-Robertson, 2004).
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The in vitro binding datum in Figure 19A coupled with the G4-recombination datum
in Figure 19D prompted me to investigate the in vivo binding of Top1 cleavage-defective
mutants at SµG4-GTOP. Thus, ChIP-qPCR was performed in top1∆ cells transformed with a
plasmid expressing a yTOP1Y727F-HA allele. To my surprise, no further enrichment of
yTop1Y727F-HA was observed at the “G4” SµG4-GTOP locus relative the negative control,
non-G4 capable “3kb” locus located ~3 kb from SµG4 (Figure 22). However, both the “G4”
and “3kb” loci are located in the same transcriptional unit in the pTET-LYS2-SµG4
recombination reporter. Thus, both G4 and 3kb are constitutively transcribed in the absence
of doxycycline. Of note, Top1 is known to be localized to genomic regions undergoing
transcription, and even interacts with RNA pol2 (Phatnani et al., 2004; Baranello et al., 2016).
Therefore, this observation that yTop1Y727F-HA SµG4-GTOP-binding does not occur more
than yTop1Y727F-HA binding to duplex DNA at a highly transcribed region could be due to
yTop1Y727F-HA still being localized to sites of active transcription despite being catalytically
inactive. Further, while yTop1Y727F G4-binding in vivo may not occur more often than
binding of yTop1Y727F at another non-G4 locus, the binding of yTop1Y727F to G4s could be
highly mutagenic, leading to the elevated recombination observed at co-transcriptionally
formed G4s (Figure 19D). Additionally, the results depicted in Figure 22 could be due to
experimental limitations of my ChIP-qPCR method.
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Figure 22. Fold enrichment of yTop1Y727F-HA at the SµG4 G4 and 3kb loci in vivo. Averages
and standard deviations of yTop1Y727F-HA fold enrichment in a top1∆ GTOP background
(n=6).
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4.2.3 The DNA-Dependent Protease Wss1 Alleviates G4-Associated Genome Instability
Exacerbated by Cleavage-Defective Top1 Mutants.
WSS1 encodes a DNA-dependent protease that degrades proteins bound to DNA
(Stingele et al., 2017; Stingele et al., 2014). Top1ccs trapped on DNA are Wss1’s best
characterized substrate. Deletion of WSS1 did not affect the recombination in WT or top1∆
backgrounds (Figure 23A) but significantly elevated the rates of recombination at the pTETlys2-GTOP construct only in yTOP1Y727F- or yTOP1Y740Stop-expressing strains (Figure 23B).
These results support that the cleavage-defective Top1 mutants trapped on SµG4 in vivo were
substrates for Wss1. WSS1-deletion did not affect the rate of recombination at the pTET-lys2GTOP construct in yTOP1S733E-expressing strains, consistent with the in vitro oligo binding
assays showing that yTop1S733E does not bind G4s formed on SµG4 GTOP (Figure 23A).
Additionally, WSS1-deletion did not affect recombination rate at the pTET-lys2-GBTM
construct in any of the strains (Figure 23A and 23B), indicating that Wss1 has a specificity for
proteins bound to G4s in our fluctuation assays and that the Top1 catalytic mutants are not
persistently bound to SµG4 when G4-formation is not supported. In wss1∆ strains, Top1 WT
and mutant proteins are SUMOylated with Top1Y727F being most extensively modified by
SUMO ligation (Figure 23C).
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Figure 23. Deletion of WSS1 increases G4-induced recombination in Top1 catalytic mutant
strains. A.-B. Recombination rates of WSS1 and wss1∆ yeast strains expressing indicated Top1
alleles. Rates are considered statistically significantly different if their 95% confidence
intervals (shown as error bars) do not overlap (Spell and Jinks-Robertson, 2004). C. Top1SUMO pull down experiment. All experiments were carried out in wss1∆ strains expressing
C-terminally 3X-FLAG-tagged Top1 proteins and N-terminally 7XHis-tagged Smt3. SUMOmodified proteins were pulled down using Ni+ beads and Top1 proteins detected by western
blotting with α-FLAG-HRP antibody. Top panel – inputs; bottom panel – pull down samples
(PD). * denoted bands are mono- or poly-SUMOylated Top1 proteins.
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4.2.4 N-terminal domain and RGG repeats of Nsr1 are required for synergistic elevation of
G4-induced genomic instability in cells with a Top1 cleavage-defective mutant.
The yeast protein Nsr1, a homolog of human nucleolin (NCL), is a G4-binding protein
required for G4-induced recombination in top1∆ cells (Singh et al., 2020). Nsr1 binds to cotranscriptionally formed G4s in the absence of yTop1 leading to replication stalling along the
SµG4-containing pTET-lys2-GTOP locus. I deleted NSR1 in the Top1 mutant backgrounds and
measured recombination at the SµG4-containing recombination reporters. NSR1-deletion
significantly reduced recombination rates at the pTET-lys2-GTOP reporter in all backgrounds
(Figure 24A-E). Deletion of NSR1 in top1∆ and yTOP1S733E strains reduced recombination at
the pTET-lys2 GTOP reporter to WT background levels (Figure 24B-C). In cells expressing
yTOP1Y727F or yTOP1Y740Stop, recombination rates at the pTET-lys2 GTOP reporter were
reduced by NSR1-deletion but were still significantly higher than WT and similar to those
measured in top1∆ (Figure 24A-B & Figure 24D-E). NSR1-deletion did not affect the
recombination rate at the pTET-lys2-GTOP reporter in a WT background (Figure 24A).
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Figure 24. Deletion of NSR1 and deletion of the RGG domain of Nsr1 reduces G4-induced
recombination in Top1 mutant strains. A.-E. Recombination rates of NSR1, nsr1∆, and
nsr1∆RGG strains expressing indicated Top1 alleles. Rates are considered statistically
significantly different if their 95% confidence intervals (shown as error bars) do not overlap
(Spell and Jinks-Robertson, 2004).
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The C-terminally located RGG repeats of Nsr1 are required for high-affinity G4-binding
(Singh et al., 2020). When I expressed a truncated form of Nsr1 lacking the RGG domain
(Nsr1∆RGG = Nsr1 amino acid residues 1-350), recombination at the pTET-lys2-GTOP reporter
was significantly reduced in all Top1 mutant strains (Figure 24C-E). As observed in the above
experiments with NSR1-deletion, recombination at the pTET-lys2 GTOP reporter was reduced
to that in WT level in the yTOP1S733E NSR1∆RGG strain but remained above WT levels in
yTOP1Y727F NSR1∆RGG and yTOP1Y740Stop NSR1∆RGG strains (Figure 24A & Figure 24C-E).
For the pTET-lys2-GBTM reporter construct, recombination rates were not affected by either
NSR1-deletion or deletion of Nsr1’s RGG domain in any background, except in the
yTOP1Y740Stop nsr1Δ strain where the recombination rate was significantly higher than the
rate in the yTOP1Y740Stop background (Figure 24A-E).
I additionally performed functional complementation experiments in nsr1∆ strains.
The N-terminus of Nsr1 (N-term Nsr1; amino acids 1-171), the C-terminus of Nsr1 (C-term
Nsr1; amino acids 171-414), or full-length Nsr1 (Nsr1 FL; amino acids 1-414) was expressed in
nsr1∆ cells expressing one of the Top1 mutants using a high copy 2µ plasmid and verified by
western blot analyses (Figure 25). Expression of C-term Nsr1 in a top1Δ nsr1Δ background
increased the recombination rate at the pTET-lys2-GTOP compared to either the vector
control or the N-term Nsr1 (Figure 26A) (Singh et al., 2020). Similar effects were observed in
the yTOP1S733E nsr1Δ strain, where expression of Nsr1 C-term, but not Nsr1 N-term,
increased recombination rates at the pTET-lys2-GTOP (Figure 26B). Notably, expression of
full-length Nsr1 resulted in greater elevation in recombination rates at pTET-lys2-GTOP than
C-term Nsr1 in both top1Δ nsr1Δ and yTOP1S733E nsr1Δ backgrounds. In the yTOP1Y727F
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nsr1Δ strain, the expression of neither C-term Nsr1 nor N-Term Nsr1 significantly changed
recombination rates at the pTET-lys2-GTOP (Figure 26C). Only expression of full-length Nsr1
(Nsr1 FL) elevated the recombination rate at the pTET-lys2-GTOP above the control in the
yTOP1Y727F nsr1Δ strain. Similar results were seen with the yTOP1Y740Stop nsr1Δ strain,
where expression of Nsr1 FL resulted in a ~ 6.5-fold elevation in recombination rates at the
pTET-lys2-GTOP relative to the vector control (Figure 26D). In the yTOP1Y740Stop nsr1Δ GTOP
strain, expression of C-term Nsr1 led to a significant but relatively moderate increase in the
recombination rate at the pTET-lys2-GTOP relative to the vector control - ~ 1.3-fold increase
compared to the 5- or 2.5-fold increase seen with the expression of C-Term Nsr1 in top1∆
nsr1∆ or yTOP1S733E nsr1∆ backgrounds, respectively (Figure 26A, B, and D). In summary,
the Top1-interacting N-terminus of Nsr1 is required to exacerbate G4-associated genome
instability induced by yTop1Y727F or yTop1Y740STOP.
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Figure 25. Nsr1 constructs are expressed from pADH1-Nterm Nsr1, pADH1-Cterm Nsr1, and
pADH1-Nsr1 in yeast. Western blot of lysates prepared from top1∆ nsr1∆ cells transformed
with control, pADH1-Nterm Nsr1, pADH1-Cterm Nsr1, and pADH1-Nsr1 plasmids. Nsr1-GST
construct blots were probed with a primary α-GST antibody (Invitrogen) and a secondary αmouse IgG-HRP antibody (R&D Systems-biotechne). Loading control blots were probed with
an α-GAPDH antibody (Invitrogen). N-term = pADH1-Nterm Nsr1, C-term = pADH1-Cterm
Nsr1, Nsr1 FL = pADH1-Nsr1, and Vec. = vector control. Quantifications of Nsr1 construct
protein levels are listed below blot.
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Figure 26. Expression of full-length NSR1 is required to greatly exacerbate G4-induced
recombination in TOP1Y727F nsr1∆ and TOP1Y740Stop nsr1∆ strains. A-D: Recombination
rates of top1∆ nsr1∆ (A), TOP1S733E nsr1∆ (B), TOP1Y727F nsr1∆ (C), or TOP1Y740STOP nsr1∆
(D) yeast strains expressing the indicated Nsr1 constructs. Rates are listed above their
respective bars and are considered statistically significantly different if their 95% confidence
intervals (shown as error bars) do not overlap. N-term = pADH1-Nterm Nsr1, C-term = pADH1Cterm Nsr1, NSR1 FL = pADH1-Nsr1, and vector = pRS426. E and F: Co-immunoprecipitation
(co-IP) experiments conducted with vtc4∆ yeast strains expressing 3XFLAG-tagged Top1
proteins and either 6X-HA-tagged full-length Nsr1 (E) or Nsr∆RGG (F). Pull down was carried
out with αFLAG antibody-coated agarose beads. Blots were probed with either αFLAG or αHA
antibodies. Quantification of binding was calculated by dividing FLAG IP pixel intensities from
HA-IP pixel intensities and presented in graphs in Figure 31.
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4.2.5 Top1 Mutants Interact with Nsr1.
Because the complete deletion of NSR1 or the expression of the Nsr1∆RGG-truncated
protein significantly reduces G4-associated recombination in cells expressing Top1 cleavagedefective mutants, I tested whether Top1 cleavage-defective mutants can bind Nsr1 to
cooperatively interact on G4 DNAs. Indeed, a G4 DNA/Nsr1/Top1-mutant complex could be
a potent block to DNA replication and thus explain the exacerbated G4-induced instability
observed in the presence of Top1 catalytic mutants and Nsr1. While interactions between WT
Top1 and Nsr1 have been shown (Edwards et al., 2000; Azevedo et al., 2015), interactions
between a Top1 mutant and Nsr1 have not been previously reported.
For co-immunoprecipitation (co-IP) experiments, C-terminally 3XFLAG-tagged Top1
mutants and C-terminally 6XHA-tagged Nsr1 were expressed in yeast cells. First, we showed
that Nsr1-6XHA is stably expressed in all Top1 mutant backgrounds (Figure 27B) and that the
C-terminal 6XHA-tag on Nsr1 does not affect G4-induced recombination at the pTET-lys-GTOP
reporter (Figure 28). All co-IP experiments were conducted in a VTC4-deletion background
because Top1/Nsr1 interactions are not easily detectable in the presence of Vtc4 protein,
which is required for the synthesis of post-translational poly-phosphorylation (Figure 29)
(Hothorn et al., 2009; Azevedo et al., 2015). VTC4-deletion did not affect the rate of
recombination at pTET-lys2-GTOP reporter in any strain expressing either full-length Nsr1 or
the Nsr1∆RGG truncation (Figure 30). In vtc4∆ backgrounds, Top1/Nsr1 interactions were
detected in lysates prepared from all Top1 protein strains tested (Figure 26E) and
quantification of multiple co-IP experiments revealed that all the Top1 proteins tested
undergo a similar level of interaction with Nsr1 (Figure 31A). Interaction between Nsr1∆RGG
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and Top1 mutants were tested through co-IP experiments in vtc4∆ strains (Figure 26F); all
three Top1 mutants, i.e. Top1Y727F, Top1Y740STOP, and Top1S733E, interacted with
Nsr1∆RGG to a similar degree (Figure 31B). Our composite co-IP data demonstrate that
neither Top1 mutation nor deletion of Nsr1’s RGG domain impacts the Top1-Nsr1 interaction.
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Figure 27. NSR1-6XHA and NSR1ΔRGG-6XHA proteins are expressed in Top1 mutant
backgrounds. A. Western blot of lysates prepared from yeast cells expressing untagged,
endogenous Nsr1 or nsr1Δ yeast cells. Untagged Nsr1 blot was probed with a primary α-Nsr1
antibody (Invitrogen) and a secondary α-mouse IgG-HRP antibody (R&D Systems-biotechne).
B-C. Western blot of lysates prepared from Top1 mutant cells expressing either HA-tagged
full length Nsr1 or HA-tagged Nsr1ΔRGG. HA-tagged Nsr1 and Nsr1ΔRGG blots were probed
with an α-HA-HRP antibody (Sigma). Loading control blots in A.-C. were probed with an αGAPDH antibody (Invitrogen).
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Figure 28. NSR1-6XHA GTOP strains and untagged NSR1 GTOP strains have comparable G4induced recombination rates A.-E. Recombination rates of Top1 mutant NSR1-6XHA GTOP
strains shown with the rates of respective parental strains. Rates are considered statistically
significantly different if their 95% confidence intervals (shown as error bars) do not overlap
(Spell & Jinks-Robertson, 2004).
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Figure 29. Top1 mutant and Nsr1 co-immunoprecipitation (co-IP) experiments in the
presence of VTC4. A. Co-IP experiments conducted with VTC4+ yeast strains expressing Top1
proteins that are C-terminally tagged with 3X-FLAG and full-length Nsr1 that is C-terminally
tagged with 6X-HA. α-FLAG coated agarose beads (Sigma) were incubated with yeast whole
cell lysates. After pull down and washing, proteins were eluted from the beads by incubation
with 3X-FLAG peptide (Sigma) and samples were ran on an SDS PAGE followed by western
blotting. Blots were probed with either α-FLAG-HRP (Sigma) or α-HA-HRP (Sigma) antibodies.
B. Co-IP experiments conducted with VTC4+ yeast strains expressing Top1 proteins that are Cterminally tagged with 3X-FLAG and Nsr1ΔRGG that is C-terminally tagged with 6X-HA. Co-IP
and western blotting was performed as in A.
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Figure 30. Deletion of VTC4 does not affect G4-induced recombination in Top1 mutant
strains. A.-E. Recombination rates of Top1 mutant VTC4+ and vtc4∆ GTOP yeast strains. Rates
are considered statistically significantly different if their 95% confidence intervals (shown as
error bars) do not overlap (Spell & Jinks-Robertson, 2004).
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Figure 31. Quantification of Top1 mutant interactions with Nsr1. A. Quantification (means
and standard deviations of Nsr1-6XHA IP pixel intensities normalized to Top1-3XFLAG pixel
intensities) of western blots from 3 co-immunoprecipitation (co-IP) experiments performed
as in Figure 26E with yeast cells expressing FLAG-tagged Top1 proteins and HA-tagged full
length Nsr1. B. Quantification (means and standard deviations of Nsr1ΔRGG-6XHA IP pixel
intensities normalized to Top1-3XFLAG pixel intensities) of western blots from 3 co-IP
experiments performed as in Figure 26F with yeast cells expressing FLAG-tagged Top1
proteins and HA-tagged Nsr1ΔRGG.
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4.3 Discussion
Co-transcriptional helical stress, promoting formation of DNA secondary structures
including G4 DNA, is expected to accumulate when Top1’s normal function of relieving DNA
supercoils by binding and cleaving DNA is completely disrupted (Redinbo et al., 1998).
Multiple studies including our lab’s previous works support the notion that Top1 functions to
prevent co-transcriptional G4-formation by removing negative helical stress (Yadav et al.,
2016; Husain et al., 2016). It remained to determine how the expression of catalytic or DNA
binding Top1 mutants found in CPT-resistant cancer cells would affect DNA aberrations at
G4s. The C-terminal domain of Top1 partly forms a tight loop around duplex DNA and contains
catalytically important residues, including the phosphotyrosyl bond-forming tyrosine (Y727
and Y723 in yeast and human, respectively) (Redinbo et al., 1998). The high conservation
between yeast and human C-terminal domains of Top1 allowed us to measure the effect of
C-terminal Top1 mutants found in CPT-resistant human cancer cells on G4-induced instability
by expressing the analogous mutants in yeast.
In an earlier study, the Kim lab found that expression of the catalytically null mutant
Top1Y727F results in severely elevated genome instability at G4 DNA-forming recombination
reporter in yeast cells. Unexpectedly, the rate of G4-associated recombination in Top1Y727Fexpressing cells was significantly higher than in top1∆ cells (Yadav et al., 2016). Here, I
expressed another cleavage defective mutant, yTop1Y740Stop, and observed similarly acute
elevation of G4-associated instability, whereas the DNA binding-defective mutant
yTop1S733E had a more moderate effect on G4-induced instability (Figure 19D). Specifically,
yTop1Y727F and yTop1Y740STOP expression resulted in pTET-lys2-GTOP recombination rates
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that were around 5.9-fold and 7.8-fold higher than when was yTop1S733E expressed. For the
pTET-lys2-GBTM reporter where G4 DNA formation was unfavorable, Top1 mutants did not
impact the rate of recombination, irrespective of the specific mutation, suggesting that the
effect of Top1 mutation on recombination is G4-specific.
Multiple studies have documented interactions of Top1 with G4s (Arimondo, 2000;
Marchand et al., 2002; Lotito et al., 2008; Berroyer and Kim, 2020). Therefore, Nayun and I
postulated that the severe elevation in recombination rates at the pTET-lys2-GTOP reporter
observed upon expression of Top1 cleavage-defective mutants Top1Y727F and
Top1Y740STOP was the result of the binding and stabilization of co-transcriptionally formed
G4s. It is possible that, while WT Top1 undergoes transient interactions with G4s in vivo, the
inability to cleave DNA subsequent to binding could leave Top1Y727F and Top1Y740STOP
trapped on G4s that form during transcription, significantly disrupting replication. Cleavagedefective mutants yTop1Y727F and yTop1Y740STOP, but not yTop1S733E, bind a G4-forming
oligo but not the control M1 oligo in vitro (Figure 19A and 19B). This result is in an agreement
with previously published data showing purified calf thymus Top1 has a specificity for G4capable oligos over non-G4 capable DNA substrates (Shuai et al., 2010). My in vitro binding
datum is in line with the GTOP recombination datum, where Top1 catalytic mutants induce
significantly greater recombination at SµG4 than the Top1 duplex DNA binding mutant (Figure
19D). Furthermore, when combined with the low steady-state protein level of
yTop1Y740Stop (Figure 16A-B), the high G4-induced recombination in yeast cells expressing
this Top1 mutant (Figure 19D) levels supports a possible dominant negative phenotype of
hTop1W736Stop.
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WSS1 encodes a SUMO-dependent metalloprotease (Stingele et al., 2014; Zhang et
al., 2020). Wss1 and its mammalian homolog SPRTN degrade proteins forming covalent,
irreversible complexes with DNA or DNA–protein cross-links (DPCs) and thus suppress
genome instability incurred by DPC-induced replication impediments (Stingele et al., 2016).
Besides DPCs occurring as trapped enzymatic intermediates, they can be generated by
crosslinking of DNA to proteins by reactive agents such as formaldehyde and metal ions. Most
Wss1 targets are SUMOylated and both Wss1 and SPRTN recognize and target Top1ccs that
are post-translationally modified (Stingele et al., 2014; Stingele et al., 2017; Juhasz et al.,
2012; Centore et al., 2012). Top1ccs have been shown to be SUMOylated (Mao et al., 2000),
and human (Top1Y723F) and yeast (Top1Y727F) Top1 catalytic mutants were found to be
more heavily SUMOylated than WT Top1 proteins (Heideker et al., 2011; Horie et al., 2002,
Chen et al., 2007). Even through non-covalent interaction, certain proteins such as yeast Fob1
or E. coli Tus can form effective DPC-like stable, high-affinity complexes with DNA that block
replication fork movement (Hizume and Araki, 2019). Recently, histones in such non-covalent
DPCs were shown to be substrates for Wss1 (Maddi et al., 2020). Nayun and I postulate that
Top1 mutants Y727F and Y740STOP, if forming replication barriers through high-affinity
interaction with G4 DNA, could be SUMOylated and targeted by Wss1-dependent proteolysis.
Upon deletion of WSS1, the recombination rates at pTET-lys2-GTOP in yTop1Y727Fand yTop1Y740STOP-expressing strains were each elevated by ~ 3-fold (Figure 23B). Since the
pTET-lys2-GTOP recombination rates in WT and top1Δ were not significantly changed by
WSS1-deletion (Figure 23A), the effect of WSS1-deletion on G4-induced recombination is
specific to the Top1 cleavage-defective mutants. Consistent with the observation where
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yTop1S733E does not appear to be tightly bound to G4 DNA in vitro and where the
recombination at pTET-lys2-GTOP did not further elevate upon expression of yTop1S733E in
top1∆ background, WSS1-deletion did not affect the recombination rate in the yTop1S733Eexpressing strain (Figure 23A). These results provide indirect evidence that Top1 mutants
Y727F and Y740STOP form stable complexes with G4 DNA in vivo and further indicate that
Wss1 can partly suppress the genome instability instigated by Top1 cleavage-defective
mutants in complex with G4 DNA.
Nsr1 is the yeast homolog of human nucleolin, a clinically relevant protein that
exhibits altered expression and localization in cancer cells (Koutsioumpa and Papadimitriou,
2014; Berger et al., 2015; Huang et al., 2019). While the primary functions of nucleolin and
Nsr1 are in pre-ribosomal RNA processing (Tajrishi et al., 2011), both nucleolin and Nsr1 are
G4-binding proteins (Hanakahi et al., 1999; Fry, 2007; Singh et al., 2020). The biological
consequence of the nucleolin-G4 DNA interaction was demonstrated by transcriptional
change in several oncogenes including MYC upon binding of nucleolin to G4s present in the
promoter (Gonzalez et al., 2009; Gonzalez and Hurley, 2010). Our group recently published
the first results showing that, in top1Δ cells, Nsr1-G4-binding is responsible for the elevated
recombination at the SµG4-containing pTET-lys2-GTOP reporter as well as for the significant
lag in DNA replication timing observed at the SµG4-containing genomic locus (Singh et al.,
2020). In the current study, I show that NSR1-deletion significantly reduces the G4-associated
genomic instability observed in all Top1 mutant yeast strains tested (Figure 24C-E). In
yTop1S733E-expressing cells, the decrease in recombination rates due to deletion of NSR1
resembles that seen in top1∆ background, indicating that the DNA-binding defect in this Top1
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mutant essentially mimics the lack of functional Top1 with no additional detrimental effect.
However, in yTop1Y727F- and yTop1Y740Stop-expressing cells, rates of recombination at the
pTET-lys2-GTOP reporter were reduced upon deletion of NSR1 but were still significantly
higher than in WT background. This indicates that Top1 cleavage-defective mutants can
instigate G4-associated instability even in the absence of Nsr1.
The C-terminal RGG domain of human nucleolin is important for the protein’s highaffinity interaction with G4 structures (Hanakahi et al., 1999; Ghosh and Singh, 2018).
Moreover, phenylalanine residues in the RGG domain of nucleolin participate in G4-binding
and G4-folding, as shown through electrophoretic mobility-shift assays and circular dichroism
spectroscopy experiments (Masuzawa and Oyoshi, 2020). Our lab’s prior work uncovered
that the C-terminally located RGG-domain of Nsr1 is required for G4-binding and the
induction of co-transcriptional G4-induced instability in the absence of Top1 (Singh et al.,
2020). In the current study, I show that deletion of the RGG domain of Nsr1 also significantly
reduces recombination rates at the pTET-lys2-GTOP reporter construct in Top1 mutantexpressing strains (Figure 24C-E). As seen with NSR1-deletion, the level of decrease in
recombination rates due to Nsr1∆ RGG in yTop1S733E-expressing cells resembles that seen
in top1∆ background. However, in yTop1Y727F- and yTop1Y740Stop-expressing cells, the
rates of recombination at the pTET-lys2-GTOP reporter were significantly higher than in the
WT background even after deleting the RGG domain. Altogether, the NSR1-deletion and
Nsr1ΔRGG fluctuation data allude to two possible models explaining how expression of both
Top1 catalytic mutants and Nsr1 leads to severely heightened recombination at pTET-lys2GTOP. One model is that the high level of G4-associated recombination in yeast cells
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expressing Top1 cleavage-defective mutants is the result of an additive effect where G4s are
more frequently bound by either Nsr1 or Top1 mutants. Alternatively, Top1 mutants and Nsr1
interacting and cooperatively binding to G4s could result in a synergistic effect.
While the exact biological relevance of the Top1/Nsr1 interaction is not completely
understood, it is thought to be related to the localization of Top1 to the nucleolus (Edwards
et al., 2000). Since rDNA located within the nucleolus is highly transcribed and Top1 relieves
transcriptional helical stress, it is conceivable that Nsr1 recruits Top1 to the rDNA locus to
maintain optimal helical torsion. I confirmed through co-IP experiments that WT yTop1 and
Nsr1 interact (Figure 26E). In addition, I found that neither Top1 mutation nor deletion of
Nsr1’s RGG domain affects Top1/Nsr1 interaction (Figure 26F). These co-IP data suggest the
effect of Top1 catalytic mutants and Nsr1 on G4-induced recombination could be synergistic
since Top1 mutants and Nsr1 interact and our lab previously showed that Nsr1 is significantly
enriched at SµG4 GTOP relative to non-G4 loci in ChIP experiments (Singh et al., 2020). I also
showed that only the expression of full-length Nsr1, but not the Nsr1 C-term or N-term
(required for interaction with Top1(Edwards et al., 2000)), increased the recombination rate
at the pTET-lys2-GTOP reporter relative to the vector control in TOP1Y727F nsr1Δ and
TOP1Y740STOP nsr1Δ cells (Figure 26C and 26D). This indicates that the synergistic effect on
G4-induced recombination requires both interaction between Nsr1 and Top1 and the
interaction between Nsr1 and G4 DNA. Altogether, my data suggest a model in which Top1
catalytic mutants and Nsr1 bind to and interact on co-transcriptionally formed G4s to form a
highly mutagenic complex that prevents G4-resolution and potentially impedes replication
fork movement through G4-motifs (Figure 32). Future experiments in the Kim lab will focus

128

on uncovering if replication through G4-motifs is disrupted in Top1 catalytic mutant cells
expressing full-length Nsr1 to better elucidate this mutagenic mechanism.
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Figure 32. Model of co-transcriptional G4-formation and the effect of Top1 activity and
mutation on G4-induced genomic instability. RNAP = RNA polymerase complex. Dotted line
= the nascent transcript. (-) = negative tension behind the transcription complex. (+) =
positive tension ahead of the transcription complex. Top1mt = Top1 mutant. N = Nsr1 N-term.
C = Nsr1 C-term. Top1mts capable of G4-binding (i.e. Top1Y727F orTop1Y740STOP) but not
Top1mts incapable of G4-binding (i.e. Top1S733E) form Top1mt/Nsr1/G4 DNA complexes that
block and cause genomic instability.
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Validating my findings regarding Top1 mutants and G4s in yeast, our collaborator, Dr.
Albino Bacolla from the Tainer lab at the University of Texas MD Anderson Cancer Center,
performed a computational analysis of the cancer genome sequencing data available in the
Catalogue

of

Somatic

Mutations

in

Cancer

(COSMIC)

database

(https://cancer.sanger.ac.uk/cosmic) to show that Top1 catalytic mutants are linked with
increased G4-instability in cancers (Figure 33). Specifically, the number of mutations (single
nucleotide polymorphisms (SNPs), short insertions, and short deletions (indels)) in 35,887
cancer genomes representing 37 different tissues (All_tumors-Figure 33A) were compared to
the number of mutations present in a group of 239 cancer genomes all harboring mutations
in human TOP1 (TOP1_mutants-Figure 33A). The TOP1_mutants group had a 12-fold higher
median number of mutations per genome relative to the All_tumors group. The
TOP1_mutants group also had a higher median number of mutations compared to the
median numbers of mutations in 5 different tumor types displaying the greatest number of
TOP1 mutants (large intestine carcinoma, skin malignant melanoma, lung carcinoma,
endometrium carcinoma, and stomach carcinoma).
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Figure 33. Somatic mutations in the TOP1 gene are associated with high mutation rates in
cancer. This bioinformatic analysis was conducted by Dr. Albino Bacolla of the Tainer lab at
the University of Texas MD Anderson Cancer Center. (A) S-plots of number of mutations
exome-wide. All_tumors, 35,887 samples from Cosmic v.94 comprising all exome-wide
screens (i.e. field “Genome-wide screen” corresponding to “y”) and non-redundant sample
codes; Large intestine carcinoma, 2,355 samples from All_tumors comprising carcinomas of
the large intestine, 44 of which had mutations in TOP1; skin_malignant_melanoma, 1,372
samples from All_tumors with malignant melanoma of the skin, 31 with mutations in TOP1;
Lung_carcinoma, 2,512 lung carcinoma samples from All_tumors, 27 with TOP1 mutations;
Endometrium_carcinoma, 606 samples from All_tumors with carcinoma in the lining of the
womb, 23 with mutations in TOP1; Stomach_carcinoma, 1,349 samples from All_tumors with
stomach carcinoma, 16 with TOP1 mutations; TOP1_mutants, all 239 samples from
All_tumors with mutations in TOP1. Horizontal dash, median. (B) Box plot shows number of
mutations in samples carrying mutations in different TOP1 domains. N-Ter, 61 samples with
mutations in the amino terminus domain (median = 878); Linker, 26 samples with mutations
in the Linker (median = 1321.5); Core, 102 samples with mutations in the Core domain
(median = 1,149); Stop, 36 samples with nonsense mutations (median = 1,219); C-Ter, 14
samples with mutations in the carboxyl terminus domain (median = 982.5); Ran, 300 samples
chosen at random among All_tumors (median = 73.5); Ran_H, random_high: a pool of 1,500
random samples with at least 400 mutations each were chosen from All_tumors and 300
entries were then chosen from the pool, after removing samples with identical codes but
assigned to different types of tumor in COSMIC (median = 1049). P-values were from
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Wilcoxon tests. For the purpose of single Wilcoxon tests, we combined the numbers of
mutations and numbers of samples when applicable. (C) Box plots of mutations at G4 tracts.
For each sample the value refers to the percent mutations that overlapped with G4-forming
repeats. Data sets are as in panel B. Stars, total number of mutations; median values are
shown. P-values from Wilcoxon tests. For the purpose of single Wilcoxon tests, we combined
the percent mutations at G4 and numbers of samples when applicable. Outliers were
removed for clarity.
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Next, the TOP1_mutant tumors group was divided into 5 groups consisting of
genomes with mutations in either TOP1’s amino-terminus (N-Ter), linker domain, core
domain, carboxy-terminus (C-Ter) as well as TOP1 truncation mutations (Stop). Since the
carboxy-terminus of TOP1 contains amino acid residues important for catalytic function, we
reasoned that C-Ter and Stop mutations are most likely to affect TOP1’s ability to cleave DNA.
The comparison between the N-Ter + Linker + Core group with the C-Ter + Stop group resulted
in no significant difference in the median number of mutations (Figure 33B). The N-Ter +
Linker + Core group as well as the C-Ter + Stop group exhibited significantly higher median
numbers of mutations compared to a set of 300 cancer genomes selected randomly from
All_tumors. However, both N-Ter + Linker + Core and C-Ter + Stop groups had median
numbers of mutations similar to the group Ran_H, another set of genomes from All_tumors
harboring a median number of mutations similar to that of TOP1_mutants.
While the data in Figures 33A and B show that TOP1 mutant genomes are
hypermutated in general, we wanted to know how TOP1 mutants affect instability occurring
at G4 potential non-B DNA-forming sequences (PONDS). Since replication stress through G4PONDS is expected to elevate SNPs and indels through mutagenic DNA break repair (Malkova
and Ira, 2013; Scully et al., 2019; Eckelmann et al., 2020), the percent mutations at G4 PONDS
was further examined. When all Top1 mutant cancer genomes were grouped together, the
percentage of mutations occurring at G4 PONDS was higher than the G4 PONDS mutations
percentage of the Ran group (medians 0.52 and 0.00, respectively) (Figure 33C). When the NTer + Linker + Core Top1 mutant group was compared to Ran_H, a lower percentage of G4
PONDS mutations was observed for N-Ter + Core + Linker. The combined C-Ter + Stop group
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had a percentage of mutations at G4 PONDS similar to the Ran_H group, but significantly
higher than the N-Ter + Core + Linker group (p-value = 0.0184). Therefore, we conclude that
mutations that impact TOP1 catalytic function affect G4-instability in cancers more than
mutations present in other TOP1 domains. This supports that expression of TOP1 cleavagedefective mutants may worsen cancer patient prognosis as a result of G4-stabilization.
In summary, I have found that expression of Top1 mutants, some of which are found
in CPT-resistant cancer cells, sharply increases the genomic instability associated with cotranscriptionally-formed G4s in yeast. A model of genome instability at G4 DNA exacerbated
by the cleavage-defective Top1 mutants is shown in Figure 32. While co-transcriptionallyformed negative supercoils accumulate in the absence of functional Top1 due to either
complete loss of the Top1-encoding gene or mutations leading to defects in DNA binding or
DNA cleavage, the G4-binding and -stabilization by the cleave-defective Top1 mutants further
enhances the instability and recombination occurring at G4-forming genomic sites. I also
discovered a new role of Wss1 in suppressing G4-associated genomic instability in presence
of Top1 cleavage-defective mutants, putatively by removing Top1 mutants trapped on cotranscriptionally formed G4s. Another important finding is that the instability at G4 DNA is
exacerbated by the interaction between yeast-nucleolin (Nsr1) and Top1 mutants. The
findings reported here are clinically relevant since Top1 mutants arise in cancer cells in
response to treatment with CPT or CPT-derivatives (Beretta et al., 2013) and human nucleolin
are frequently overexpressed or mis-regulated in cancer cells (Berger et al., 2015;
Koutsioumpa and Papadimitriou, 2014; Huang et al., 2019). The clinical relevance is further
underscored by Albino’s finding that mutations in Top1 correlate with high mutation
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frequencies throughout the genome, and that mutations in the catalytic carboxy terminal
domain of Top1 correlate with enrichment of mutations at G4 PONDS. Overall, our results
suggest that the expression of Top1 mutants could induce additional genome
rearrangements in cancer cells by supporting G4-formation and -stabilization. The resulting
genomic rearrangements originating at G4-motifs may lead to secondary cancer
development greatly complicating patient treatment. Other studies have documented
secondary cancer development in patients following treatment with CPT-derivatives
(Merrouche et al., 2006; Li et al., 2019). In the future, it will be valuable to explore how CPTtreatment and subsequent emergence of Top1 mutants can lead to further genome instability
and potential secondary cancers.
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Chapter 5: Discussion and Future Directions
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5.1 Summary
Many protein factors that regulate DNA topology, transcription, and chromosome
packaging interact with G-quadruplexes and impact the genomic instability associated with
them. The dissertation work described here set out to uncover how loss of Top1 activity,
either through Top1-deletion or mutation, enhances the genomic instability associated with
G-quadruplex non-B DNA structures in S. cerevisiae. This work also explored if and how the
activities of different yeast proteins (Wss1 and Nsr1) enhance or suppress G4-induced
instability in the absence of functional Top1.
Chapter 3 describes my attempts at determining if a greater number of G4s form in
the highly-transcribed regions of the yeast genome in the absence of Top1 than in Top1’s
presence. While my approach of expressing the G4-specific antibody BG4 from a vector in
yeast to perform ChIP-seq and immunofluorescence for G4 quantification was unsuccessful,
I discuss ways to improve both ChIP-seq and immunofluorescence approaches. I also discuss
alternative approaches to test our hypothesis that more G4s form in a TOP1-deletion strain
than in a WT strain. In Chapter 4 of this dissertation, I explore expressing of “loss of function”
mutants of Top1 impacts G4-induced genomic instability in yeast and find that Top1 cleavagedefective mutants enhance G4-induced genomic instability significantly more than a Top1
duplex DNA binding mutant. While the Wss1 protease of the DNA-protein crosslink repair
pathway plays a role in preventing G4-induced recombination in yeast strains expressing
Top1 cleavage-defective mutants, the G4-stabilizing protein Nsr1 works together with Top1
cleavage-defective mutants to enhance G4-instability in a synergistic fashion. The results
presented in Chapter 4 are clinically relevant as Top1 cleavage-defective mutants are found

139

in cancer cells resistant to the anticancer Top1-targeting drug CPT. Collectively, the work
described in Chapter 4 indicates that Top1 mutants found in chemotherapy-resistant cancer
cells could induce secondary genomic rearrangements involving G4-capable loci. In the next
sections of this chapter, I discuss future directions of the work outlined in this dissertation.
5.2 Enumeration of G4s in the complete absence of Top1 in Yeast
In light of multiple pieces of evidence showing human and yeast Top1 suppress cotranscriptional G4-induced genomic instability (Kim and Jinks-Robertson, 2011; Yadav et al.,
2014; Yadav et al., 2016; Husain et al., 2016), we hypothesized that a greater number of G4
DNA structures form during transcription in the absence of functional Top1. Understanding
how Top1 depletion impacts G4-formation on a genome-wide scale is important since Top1
is the target of widely-used anticancer drugs that can lead to loss of function Top1 mutants
(Pommier et al., 2010) and G4s are associated with oncogenic translocations and contribute
to the mutational burden of cancer cells (Bacolla et al., 2016; Bacolla et al., 2019).
Here, I attempted to express a FLAG-tagged version of the BG4 antibody to perform
ChIP-seq and immunofluorescence experiments to compare the number of G4s that form in
WT and top1∆ cells genome-wide. I expected to observe significantly more BG4 enrichment
at highly transcribed regions of the yeast genome in TOP1-deletion cells relative to WT cells
in ChIP-seq. I also expected to observe more BG4 puncta in the nuclei of TOP1-deletion cells
than in the nuclei of WT cells (Figure 12). While BG4-FLAG was expressed in yeast (Figure 8)
and was found to be functional in terms of G4-binding in vitro (Figure 10), ChIP experiments
revealed that BG4-FLAG expressed from pGAL-BG4-FLAG was not enriched at our model
SµG4-motif in yeast (Figure 11). The immunofluorescence experiments performed in cells
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transformed with pGAL-BG4-FLAG were also unsuccessful (Figure 13). One reason the ChIP
and immunofluorescence experiments failed could be that BG4-FLAG expressed from pGALBG4-FLAG was not localized to the nucleus. Thus, a nuclear localization signal sequence
should be added to the expressed BG4 construct in effort to increase the likelihood that BG4
will contact G4s in the yeast genome. Additionally, purified BG4-FLAG could be used for ChIPseq and immunofluorescence experiments.
In addition to optimizing methods to quantify the number of G4s in yeast in the
absence of Top1, the genome-wide formation of other non-B DNAs in Top1-deficient cells
should be quantified in the future as well. Multiple lines of evidence indicate that Top1
suppresses the genomic instability associated with other non-B DNA structures by removing
co-transcriptional negative helical tension. For example, R-loops are formed during
transcription when the nascent mRNA loops back to hybridize with the transcribed DNA
strand and are a source of genomic instability (Hamperl and Cimprich, 2014). TopA in E. coli
and Top1 in yeast are linked to the suppression of R-loop mediated cytotoxic effects. TopA is
the enzyme responsible for removing DNA negative supercoils in E. coli (Drolet, 2006). In the
absence of TopA function, the accumulation of negative supercoils can perturb E. coli growth
and RNA production (Drolet et al., 1994; Baaklini et al., 2004; Baaklini et al., 2008). Because
TopA null E. coli RNA synthesis and growth defects are rescued in part by overexpression of
the R-loop resolving enzyme RNase H, it was concluded that excessive DNA negative
supercoils promote R-loop formation in E. coli (Drolet et al., 1995; Baaklini et al., 2004). In
yeast, ChIP experiments from El Hage et al., 2010 showed that R-loop formation at ribosomal
DNA in cells conditionally depleted of Top1 is increased in the absence of R-loop processing
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enzymes RNase H1 and RNase H2. Electron microscopy experiments from this same work
revealed that pile ups of RNA polymerase I on ribosomal DNA occur more frequently in cells
lacking Top1 than in WT cells, suggesting that increased R-loop formation in the absence of
Top1 blocks RNA polymerase I progression. It has also been shown that Top1 suppresses
genomic instability associated with repetitive DNA loci capable of forming DNA hairpin
structures. DNA sequences containing multiple CAG/CTG repeats can form stable DNA
hairpins composed of intra-strand base pairs (Petruska et al., 1996). In human cells, knock
down of TOP1 with siRNAs resulted in significantly increased contraction of a trinucleotide
repeat track containing 95 CAG repeats (Hubert et al., 2011). Of note, the instability of the
CAG repeat track in TOP1 knock down cells was dependent on transcription. Since Top1
suppresses genomic instability associated with CAG repeats, it is possible that a greater
amount of hairpin structures form at inverted repeats on a genome-wide scale in the absence
of Top1. Cruciforms (two DNA hairpins located opposite to one another in dsDNA), triplexes
(three-stranded DNA), and Z-DNA (left-handed DNA helix) are other non-B DNA structures
that form in negatively supercoiled DNA (Zhao et al., 2010); therefore, TOP1-depletion is
expected to increase their formation as well.
Further, the impact of other Topoisomerases, such as Topoisomerase 2 and
Topoisomerase 3, on the prevention of formation of G4s and other non-B DNAs should be
examined. Yeast topoisomerase 2 (Top2) is a type 2A topoisomerase that cleaves both strands
of duplex DNA and relieves helical torsion via the passage of an intact DNA duplex through
the cut DNA duplex (Pommier et al., 2016). In addition to relieving both positive and negative
DNA supercoils, yeast Top2 is essential due to its ability to decatenate sister chromatids that
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become interlocked during replication. A temperature sensitive Top2 mutant (top2-ts) that
exhibits no Top2 activity at 35 °C and very weak Top2 activity at 26 °C has allowed for
researchers to investigate how Top2-depletion affects helical stress (Goto and Wang, 1985;
Christman et al., 1988; Trigueros and Roca, 2001). In yeast strains either lacking Top1 or
expressing top2-ts, transcription-induced DNA supercoiling of the rDNA repeats was
visualized using high-resolution microscopy and showed that Top1 primarily relieves DNA
negative supercoils accumulating behind RNA polymerase I while Top2 primarily relieves DNA
positive supercoils that accumulating in front of RNA polymerase I (French et al., 2011).
Although the study mentioned above indicates distinct roles of Top1 and Top2 in resolving
negative and positive supercoils, respectively, Top2 does have the ability to relieve DNA
negative supercoils and is thought to play redundant roles in cells as Top1 when Top1 is
absent (Trigueros and Roca, 2002; Pommier et al., 2016). The redundant role of Top2 in the
relief of transcription-associated negative supercoils is underscored by results showing that
the slow growth phenotype of yeast cells depleted of both Top1 and Top2 function at the
same time is rescued by the controlled ectopic expression of either Top1 or Top2 alone
(Trigueros and Roca, 2002). Interestingly, overexpression of E. coli TopA, an enzyme that
exclusively removes negative supercoils from DNA, also rescues the slow growth phenotype
of the top1∆ top2-ts yeast cells at 26 °C, tying this observed growth defect to negative helical
torsion (Trigueros and Roca, 2002). This piece of data taken together with the observation
that TOP1-deletion yeast cells do not display a slow growth phenotype suggest that Top2
does act to relieve negative helical tension, at least partially, in the absence of Top1.
Therefore, the potential extra negative supercoil accumulation occurring during Top2
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depletion in the absence of Top1 may increase R-loop and/or G4-formation in yeast and
should be explored in the future.
Yeast Top3 is a type 1A topoisomerase that uses Mg2+ as a metal cofactor to perform
its catalytic cycle (Pommier et al., 2016). Top3 can resolve DNA negative supercoils,
hemicatenanes, double Holliday junctions, and displacement (D-loops). Vegetatively growing
yeast cells can tolerate TOP3-deletion, while cells reproducing sexually cannot complete
meiosis in the absence of Top3 (Wallis et al., 1989; Gangloff et al., 1999). Loss of Top3β in
human cells led to an increase in R-loops, indicating that human Top3 plays a role in
suppressing R-loop formation and/or stability (Zhang et al., 2019). Interestingly, yeast Top3
was shown to have a strong binding preference for single-stranded DNA in an experiment
utilizing purified protein and a negatively supercoiled heteroduplex DNA molecule containing
a 29 base pair melted region (Kim and Wang, 1992). Further supporting yeast Top3 as a singlestranded DNA specific topoisomerase, yeast Top3 was shown to dissolve D-loops that were
formed by Rad51 and Rad54 activities (Fasching et al., 2015). D-loops, while made of only
DNA, are similar to R-loops in that they comprise a displaced single DNA strand (Kasamatsu
et al., 1971). Since human Top3β can resolve R-loops and yeast Top3 can resolve D-loops and
has reported specificity for single-stranded DNA substrates, it is possible that deletion of
yeast TOP3 will result in increased formation of R-loops. Although elevated recombination at
G4 in the absence of Top1 is not dependent on R-loop-stability as overexpression of RNase
H1 does not reduce G4-recombination at the SµG4-GTOP reporter in yeast (Yadav et al.,
2014), increased R-loop-formation due to Top3 absence could still increase the chances of
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G4-formation. Therefore, it will be interesting to uncover if Top3 plays a role in suppressing
G4-formation/instability.
Lastly, in addition to preventing the formation of G4s and other non-B DNAs, Top1
may play an important role in the resolution of formed G4s. Human Top1 interacts with the
SV40 T antigen, which unwinds duplex DNA as well as G-quadruplex DNA (Stahl et al., 1986;
Baran et al., 1997; Haluska and Rubin, 1998; Tuesuwan et al., 2008). Interactions between
human Top1 and the Werner G4-helicase have also been documented (Lebel et al., 1999;
Mendoza et al., 2016). Thus, it is possible that human Top1 recruits Werner and/or SV40 T
antigen helicases to G4s through its capability to bind G4s (Arimondo, 2000; Marchand et al.,
2002). The yeast homolog of the Werner helicase is Sgs1, which also interacts with Top1 (Watt
et al., 1996; Mankouri and Morgan, 2001). Therefore, the relevance of the Top1/Sgs1
interaction in suppressing G4-induced genomic instability should be further explored as well
as other potential Top1/G4-resolvase interactions.
5.3 Role of Cleavage-Defective Top1 Mutants in G4-Induced Genomic Instability
As described above, TOP1-deletion significantly enhances recombination at the
highly-transcribed SµG4-GTOP locus (Kim and Jinks-Robertson, 2011; Yadav et al., 2016). This
increase in G4-instabilty is hypothesized to be the result of increased G4-formation due to
rises in co-transcriptionally-derived DNA negative supercoils caused from lack of Top1
function. In past work, our group uncovered that expression of the cleavage-defective yeast
Top1 mutant, yTop1Y727F, increases co-transcriptional G4-recombination even more than
TOP1-deletion (Yadav et al., 2016). Since the same levels of DNA negative supercoils are
expected to form in top1∆ and yTOP1Y727F cells, the finding that expression of a Top1
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catalytic mutant induces greater levels of G4-instabity in yeast was surprising. Further
investigation revealed that yTop1Y727F binds G4s in vitro (Berroyer and Kim, 2020) (Figure
3). Thus, I hypothesized that G4-binding of yTop1Y727F stabilizes G4s and leads to the
observed hyper-recombination at the SµG4-GTOP construct. Instability and recombination at
G4 is acutely elevated by the expression of a cancer-associated catalytically inactive Top1
mutant (yTop1Y740Stop) capable of binding both duplex DNA (Figure 18) and G4 DNA (Figure
19A-B). This suggests that cleavage-defective Top1 mutants induce genomic instability at G4s
by a shared mechanism.
Since the tight-binding of proteins to DNA can block DNA replication and cause DNA
breaks (Gadaleta et al., 2017), I further hypothesize that the exacerbated G4-associated
recombination observed in cleavage-defective Top1 mutant yeast cells is caused from
replication stress induced from Top1 mutants binding at G4s. This hypothesis should be
tested in the future via a technique developed in the Kim lab to assess kinetics of DNA copy
number change during S-phase. This new method was used to show expression of full-length
Nsr1, but not Nsr1ΔRGG, results in a significant delay in replication timing through a G4-motif
(SµG4-GTOP) relative to a non-G4-motif (SµG4-GBTM) in the absence of Top1 (Singh et al.,
2020). This indicates Nsr1-G4 binding induces replication stress through the SµG4-GTOP
locus. In this experiment, yeast cells were first arrested at G1 with α-factor followed by
release into S-phase. Genomic DNA was isolated from the cells at 10-minute intervals from 1
to 120 minutes following release from G1 arrest. Isolated DNA from every time point was
then subjected to droplet digital PCR (ddPCR), a technique used to quantify the absolute
number of nucleic acid molecules present in a sample (Batrakou et al., 2018), and assessment
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of DNA copy number throughout S-phase was used to determine replication kinetics (i.e. time
it takes cells to duplicate DNA at a targeted genomic locus). To measure the absolute copy
number of genomic loci surrounding SµG4 throughout S-phase in cleavage-defective Top1
mutant backgrounds, primers targeting multiple loci located at and downstream of ARS306
on yeast chromosome III can be used in ddPCR experiments. Locations primers can target
upstream of SµG4 (ARS306 and kanMX4) or downstream of SµG4 (3’ lys2 and STE50) on
chromosome III are shown in Figure 34A. If binding of cleavage-defective Top1 mutants to
G4s induces replication stress, I expect a significant lag in replication will be observed in GTOP
cells relative to GBTM cells at loci downstream of SµG4 (3’ lys2 and STE50) (Figure 34B).
Conversely, no differences in replication kinetics are expected between GTOP and GBTM in
Top1 mutant strains at loci upstream of SµG4 (ARS306 and kanMX4) (Figure 34B).
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Figure 34. Expected results of proposed ddPCR replication kinetics experiment. A. Schematic
of chromosome III showing locations of ARS306 and loci upstream and downstream of SµG4
to be targeted in ddPCR. B. Expected outcome of ddPCR experiment of 2 loci presented as
DNA copy number of cell populations throughout S-phase in Top1 cleavage-defective mutant
GTOP and GBTM strains.
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As described in Chapter 4, I also found that Wss1 of the DNA protein crosslink removal
pathway plays a role in suppressing G4-induced genomic instability in yeast strains expressing
cleavage-defective Top1 mutants. Yeast Wss1 and its human homolog SPTRN are proteases
that degrade replication blocking protein DNA complexes (Stingele et al., 2014; Stingele et
al., 2016). Wss1 harbors a SUMO-interacting motif and degrades SUMOylated proteins
(Mullen et al., 2010). Since I found that Wss1 partly suppresses recombination at SµG4-GTOP
in Top1 catalytic mutant backgrounds (Figure 23B) and that Top1 catalytic mutants are
SUMOylated (Figure 23C), Wss1 likely targets the SUMOylated form of cleavage-defective
Top1 mutants. Therefore, future experiments should be conducted with lysates from WSS1+
and WSS1- yeast cells to determine if the presence of Wss1 reduces the cellular levels of
SUMOylated Top1 catalytic mutants (yTop1Y727F and yTop1Y740Stop). Further, Top1 has
been shown to be SUMOylated at three specific amino acid residues located in the Nterminus of the enzyme: Lys65, Lys91, and Lys92 (Chen et al., 2007). Mutation of all three
lysines to arginines results in a ~95% reduction in Top1 SUMOylation. In order to probe the
relevance of Top1 mutant SUMOylation in the suppression of G4-induced genomic instability,
all three Top1 SUMOylation sites should be mutated to arginines and its effect on
recombination at SµG4-GTOP and SµG4-GBTM should be determined. Yeast SUMO ligases
Siz1 and Siz2 (Jalal et al., 2017) should also be deleted in Top1 mutant yeast strains to uncover
if their ability to SUMOylate Top1 is relevant in the suppression of G4-induced genomic
instability.
The Kim lab has previously shown that Nsr1 binds G4s and instigates G4-induced
genomic instability in the absence of yeast Top1 (Singh et al., 2020). I found that Nsr1 also
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contributes to G4-recombination in the presence of Top1 mutants (Figure 24C-D). Since
deletion of the C-terminal RGG domain of Nsr1, which is responsible for Nsr1-G4 binding,
significantly reduces G4-recombination in Top1 mutant expressing strains (Figure 24C-D), I
conclude that G4-binding is the mechanism of Nsr1-induced G4-instability in Top1 mutant
cells. While NSR1-deletion or truncation of Nsr1 reduces GTOP recombination to WT levels in
top1∆ and yTOP1S733E strains, deletion or truncation of Nsr1 only reduces yTOP1Y727F and
yTOP1Y740Stop GTOP recombination to TOP1-deletion levels (Figure 24B-D). This indicates
that while Top1 cleavage-defective mutants and Nsr1 are a highly mutagenic combination in
terms of the instigation of G4-induced genomic instability, expression of Top1 cleavagedefective mutants alone can cause G4-associated recombination. I also found that the Nterminus of Nsr1 is required for induction of Nsr1-mediated G4-induced genomic instability
in the yTOP1Y727F and yTOP1Y740Stop cleavage-defective mutant strains (Figure 26C-D).
This suggests that the physical interaction of Nsr1 and Top1 mutants as well as binding of G4
DNA by both proteins is necessary to exert a synergistic effect on elevating G4-associated
recombination (Figure 32). To further elucidate the mechanism of G4-induced genomic
instability in cells expressing both Top1 cleavage-defective mutants and Nsr1, future
experiments should be conducted to determine if Top1 mutants and Nsr1 bind the same G4molecule at the same time. Such future experiments could include a sequential pull down
where photocleavable biotinylated G4-oligos conjugated to streptavidin magnetic beads are
first mixed with yeast cell lysates containing FLAG-tagged Top1 mutants to separate G4binding proteins from non-G4 binding proteins. Following photocleavage to separate G4oligos from the streptavidin magnetic beads, a second pull down can be done with α-FLAG
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coated agarose beads to pull down G4 oligos bound by FLAG-tagged Top1 mutants. After
proteins are eluted from oligos and α-FLAG beads, western blotting utilizing α-FLAG and αNsr1 antibodies can be performed to determine if Top1 mutants and Nsr1 bind G4 oligos
simultaneously. Additionally, Nsr1-ChIP should be conducted to determine whether
enrichment of Nsr1 at G4 loci is enhanced by its interaction with Top1 catalytic mutants.
One of the ways cells combat G4-induced genomic instability is through the resolution
of G4s by a subset of helicases. ChIP-seq experiments performed in S. cerevisiae revealed that
the G4-unwinder Pif1 is enriched at G4-motifs and that deletion of Pif1 results in replication
stress and increased DNA breaks at G4-motifs (Paeschke et al., 2011). Additionally, while it is
hard to imagine G4 helicases are able to unwind G4s in the presence of cleavage-defective
Top1 mutants, past work from our group suggests Pif1 may resolve a portion of G4s in Top1
catalytic mutant cells. Lopez et al., 2017 demonstrated that the yeast transcription factor
Sub1, homolog to human PC4, binds G4s and prevents G4-induced recombination in TOP1deletion cells. Genetic experiments further showed that Sub1 likely suppresses G4-instability
by recruiting G4-helicase Pif1 to co-transcriptionally formed G4s so they can be unwound.
Interestingly, deletion of SUB1 significantly increases G4-induced recombination in yeast in
the yTOP1Y727F background (Lopez et al., 2017). This means it is possible that Sub1 recruits
Pif1 to G4s in the presence of Top1 cleavage-defective mutants. While it remains to be tested
if Pif1 can metabolize G4s that are bound by Top1 catalytic mutants, Pif1 may be able to
access G4s after Wss1 has proteolytically removed Top1 cleavage-defective mutants from the
structure. Further work needs to be done to elucidate how Sub1 reduces G4-instability in the
yTOP1Y727F background and if Pif1 is involved. To start, PIF1 can be deleted in yTOP1Y727F
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and yTOP1Y727F sub1∆ backgrounds to uncover if Sub1 and Pif1 work together to suppress
G4-induced recombination. Future work should also determine if Sub1 impacts G4-associated
recombination in the cancer mutant homolog yTOP1Y740Stop background.
5.4 Yeast Chromatin Remodelers and G4-Induced Genomic Instability
In addition to being tied to transcriptional regulation, G4s are also linked to
epigenetics and chromatin structure. First off, G4-formation can impact the epigenetic
modification of DNA bases. Cytosine residues can be methylated by DNA methyltransferase
enzymes (Li et al., 1992; Okano et al., 1999; Liao et al., 2015). One DNA methyltransferase,
DNMT1, binds G4s both in vitro and in vivo, and DNMT1 G4-binding inhibits DNTM1’s catalytic
activity (Mao et al., 2018). Interestingly, G4s were found to form near sparsely methylated
CpG islands in the human genome, therefore, it was concluded that G4-formation can prevent
CpG island methylation by preventing DNTM1 activity. Since cytosine methylation can impact
transcription by affecting DNA structure and ability of transcription factors to bind to their
target sites (Yin et al., 2017), any change in cytosine methylation resulting from G4-formation
could impact transcription. Therefore, loss of Top1 function could impact transcription by
promoting G4-formation and consequently decreasing cytosine methylation. G4-formation
and -stability can also impact the presence of modified histone proteins in the genome.
During DNA replication, histone marks of parental nucleosomes are maintained by chaperone
proteins that insert the modified parental nucleosomes into the newly synthesized DNA
(Alabert et al., 2017; Hammond et al., 2017). Stabilized G4s can block the progression of DNA
polymerases, leading to post-replicative gaps where the replication of problematic G4capable motifs becomes uncoupled from bulk DNA replication when replication restarts
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downstream of the G4-block (Sarkies et al., 2010; Sarkies et al., 2012). Such uncoupling of
replication is accompanied by the deposition of new nucleosomes lacking parental histone
modifications into G4-capable genomic regions, resulting in a loss of epigenetic information
that impacts transcription. Depletion of Rev1, a translesion polymerase associated with the
destabilization of G4s (Eddy et al., 2014), and of FANCJ, a helicase that is capable of unwinding
G4s (Wu et al., 2008), leads to loss of parental epigenetic marks at G4-motifs in cells; thus,
loss of Top1 may impact the recycling of modified parental histones in G4-motifs during
replication as well since TOP1-deletion increases G4-instability. Other data showing that 98%
of G4s in human keratinocytes are located in nucleosome free genomic regions (HänselHertsch et al., 2016) suggest that G4s may prevent nucleosome deposition. The suppression
of nucleosome assembly on DNA by G4s located near TSSs could explain the observed
association of genes harboring G4s with increased transcriptional output (Du et al., 2008).
Additionally, since G4s can exclude nucleosomes, increased formation and stabilization of
G4s in the absence of functional Top1 could greatly impact the chromatin landscape of cells.
While G4s may serve to exclude nucleosomes from DNA and affect epigenetic
modification of DNA bases and histones, thus potentially impacting the overall architecture
of chromatin, multiple studies have documented connections of chromatin remodeling
proteins with G4s and other non-B DNAs. For example, ATRX was shown to suppress the
formation of R-loops at telomeric DNA sequences and bind to G-quadruplex (G4) DNA
structures in vitro and in vivo (Law et al., 2010; Nguyen et al., 2017). ATRX is a chromatin
remodeler that belongs to the SWI/SNF family that functions in complex with the histone
chaperone DAXX to suppress transcription by insertion of the H3.3 histone variant into DNA
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(Argentaro et al., 2007; Wong et al., 2010; Lewis et al., 2010). Interestingly, ATRX’s genomic
localization is enriched at centromeric, pericentromeric, ribosomal, and telomeric DNA
sequences which all contain tandem repeats and have the ability to adopt non-B DNA
structures (McDowell et al., 1999; Gibbons et al., 2000; Law et al., 2010; De La Fuente et al.,
2011; Elsasser et al., 2015). In addition to being enriched at telomeres, ATRX has also been
shown to suppress the alternative lengthening of telomeres (ALT) pathway (Heaphy et al.,
2011), a mutagenic mechanism involving the homology directed repair of broken DNA that
cancer cells use to preserve the length of their telomeres (Cesare and Reddel, 2010). Further,
since telomeres contain G4-capable DNA sequences, it is reasonable to postulate that ATRX
may have some connection to G4-mediated genomic instability. Nguyen et al., 2017
investigated the recruitment of ATRX to G4-capable telomeric DNA repeats that were
inserted into an intron of a genomic GFP gene controlled by a doxycycline-inducible promoter
in mouse cells. Usage of this reporter system containing G4-capable telomeric repeats lead
to the discovery that ATRX only bound co-transcriptionally-formed G4s when guanine-rich
DNA is present on the non-transcribed strand (NTS), which is consistent with other studies
that showed the interaction of bona-fide G4-binding proteins with G4-capable DNA is
dependent on transcriptional orientation (Lopez et al., 2017; Singh et al., 2020). Additionally,
Nguyen et al., 2017 observed that the levels of ATRX in vivo G4-binding were dependent on
the number of telomeric repeats present in the GFP gene, where longer tracts of telomeric
repeats with a high propensity to form G4s resulted in greater ATRX enrichment than shorter
telomeric repeat tracts. Based on this finding, Nguyen et al., 2017 proposed that ATRX is
recruited to telomeres by G4s, and this recruitment may play a role in suppressing ALT. A
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separate study by Teng et al., 2021 revealed that ATRX and DAXX insert H3.3 into DNA
harboring G4-motifs to promote the formation heterochromatin which ultimately suppresses
the genomic instability associated with G4s by hindering G4-formation (Teng et al., 2021b).
The two aforementioned studies taken together with results demonstrating that ATRX
exogenous expression decreases the number of G4s in cells (Wang et al., 2019) supports a
model where ATRX may have a role in G4-resolution and in the suppression of G4-formation
to protect the genome from replication stress.
Another study implemented the chromatin remodeler SMARCA4 in suppressing G4induced genomic instability. SMARCA4 is an ATP-dependent chromatin remodeler that plays
roles in the regulation of transcription and DNA repair (Chetty and Serra, 2020). Interestingly,
SMARCA4 has been documented to play both tumor suppressive and tumor supportive roles
in cancers (Ramos et al., 2014; Kim et al., 2021). Interestingly, a study showed that SMARCA4
siRNA knock down results in increased Igh/c-Myc translocations in mouse B-cell lymphoma
cells (Husain et al., 2016). Because the Igh/c-Myc translocation is a G4-associated
translocation where G4s form at the Igh and c-Myc break sites (Duquette et al., 2004; Sun
and Hurley, 2009), SMARCA4 is linked to G4 DNA. Experiments assessing the in vivo
enrichment of Top1 at the Igh locus showed that Top1 recruitment to Igh was significantly
reduced when SMARCA4 is depleted (Husain et al., 2016). It was also shown that knock down
of either SMARCA4 or Top1 increased negative supercoil levels of the highly transcribed Igh
locus in mouse B-cells. Therefore, it was concluded that SMARCA4 recruits Top1 to G4capable loci so that Top1’s activity of resolving DNA negative supercoils suppresses G4formation and associated DNA breaks.
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It remains unknown if yeast chromatin remodelers are involved in protecting the
genome from G4-mediated DNA damage. Thus, I set out to determine if deletion of yeast
chromatin remodelers influences recombination at the GTOP and GBTM reporters. Since
yeast chromatin remodeler Fun30 was identified as a G4-interacting protein in whole cell
extracts in an in vitro G4-oligo pull down assay followed by mass spectroscopy (Kim lab
unpublished datum, not shown), I started by exploring if FUN30-deletion affects G4-induced
genomic instability. Fun30 is a SWI/SNF (SWitch/ Sucrose Non-Fermentable), ATP-dependent
chromatin remodeler with roles in histone-dimer exchange, gene silencing, and end resection
of double-strand DNA breaks (Flaus et al., 2006; Neves-Costa et al., 2009; Awad et al., 2010;
Chen et al., 2012). I found that, in the WT yeast background, deletion of FUN30 did not affect
GTOP or GBTM recombination (Figure 35A). However, when I deleted FUN30 in the TOP1deletion background, I observed a significant ~2-fold increase in recombination at SµG4-GTOP
(Figure 35B). Since GBTM recombination was not affected by FUN30-deletion in the absence
of Top1, Fun30 plays a role in suppressing recombination that is G4-specific. To verify that
the absence of Fun30 increases G4-induced recombination in the absence of Top1, I next
deleted TOP1 in the fun30∆ background (Figure 35B, fun30∆* strain). Again, I saw that the
absence of both Top1 and Fun30 significantly increases recombination at the SµG4-GTOP
reporter only. Therefore, I conclude that Fun30 has an unknown role in suppressing G4induced genomic instability in the absence of Top1 when G4-formation is favored due to
increased accumulation of co-transcriptionally formed negative DNA supercoils. In the future,
experiments should be conducted to uncover exactly how Fun30 suppresses G4-induced
genomic instability. For example, ChIP could be performed to uncover if Fun30 interacts with

156

G4-capable loci in vivo. And in vitro experiments could be completed to decipher if Fun30
binds G4-oligos directly. Other areas of future exploration include assessing if Fun30’s ATPase
and/or helicase activities are required for suppression of G4-induced recombination.
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Figure 35. Deletion of FUN30 increases G4-induced recombination in TOP1-deletion strains.
A-B. Recombination rates of fun30∆ GTOP and GBTM strains in WT (A) and top1∆ (B)
backgrounds. Rates for each strain are listed above their respective bars in graph.
Recombination rates are considered statistically significantly different if their 95% confidence
intervals (shown as error bars) do not overlap (Spell and Jinks-Robertson, 2004). In B,
fun30∆* denotes strains where TOP1 was deleted in a FUN30-deletion background.
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Since Fun30 deletion alone does not affect G4-induced recombination and only
impacts instability when Top1 is also deleted (Figure 35), it is not likely that Fun30 has a role
in recruiting Top1 to G4-capable loci undergoing transcription as has been documented with
the SMARCA4 chromatin remodeler (Husain et al., 2016). Instead, Fun30 may have another
role in suppressing G4-induced recombination related to its documented role in promoting
silencing of reporter genes inserted into ribosomal DNA repeats and telomeres in yeast
(Neves-Costa et al., 2009). Of note, both ribosomal DNA and telomeres are G4-capable (Capra
et al., 2010), indicating it is possible that Fun30’s role in gene silencing could involve G4recognition and/or binding. In support of Fun30 having a possible role in suppressing
transcription of G4-capable loci or loci proximal to G4s, mammalian ATRX has been shown to
promote the formation of heterochromatin as a mechanism to block transcription and
prevent genomic instability at G4-capable genomic loci in murine embryonic stem cells (Teng
et al., 2021b). While the exact mechanism of Fun30 gene silencing at the ribosomal DNA loci
remains to be elucidated, it is possible that Fun30 functions to repress G4-induced genomic
instability in a similar fashion to ATRX by inserting histone proteins into DNA to promote
chromatin condensation and repress transcription. In addition, whether SMARCAD1, a
human homolog of Fun30 (Awad et al., 2010), represses G4-instability in mammalian cells
remains unknown and should be tested in the future.
In addition to Fun30, the role of other yeast chromatin remodelers (i.e. the Ino80
complex that plays a role in repair of DNA double-strand breaks (Morrison et al., 2004; van
Attikum et al., 2007), in genome instability at G4s should be investigated. And as mentioned
above, murine SMARCA4 was shown to recruit Top1 to G4s and suppress G4-induced
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instability (Husain et al., 2016). Therefore, it is possible a yeast chromatin remodeler also
recruits Top1 to highly-transcribed G4-capable genomic loci as well. Studying whether the
recruitment of Top1 cleavage-defective mutants by SMARCA4 or other chromatin remodelers
could contribute to oncogenic translocations at highly-transcribed G4-capable loci is another
attractive area of exploration in the future.
5.5 Overall Conclusions
The work attempted in chapter 3 is important because uncovering if a higher number
of G4s form in the highly-transcribed regions of TOP1-deletion yeast cells relative to WT yeast
cells will contribute to a better understanding of Top1’s role in suppressing G4-induced
genomic instability. Investigating the genome-wide formation of G4s in the absence of Top1
is also medically relevant since Top1 is a major target of highly used anti-cancer drugs, such
as CPT-derivatives (Pommier et al., 2010).
Top1 mutants arise in cancer cells in response to chemotherapeutic treatment
(Beretta et al., 2013). Since these mutants are catalytically faulty, their expression is coupled
with an increase of DNA negative supercoils levels which impacts non-B DNA-formation and
associated genomic instability. I found that Top1 mutants, including some found in cancers,
increased G4-induced genomic instability in yeast.
The scientific findings uncovered in Chapter 4 of this dissertation are important since
nucleolin is commonly overexpressed in cancers (Carvalho et al., 2021), G4-DNA contributes
the mutational burden of cancer cells (Bacolla et al., 2019), and Top1 is a target of widely
used chemotherapeutics that cancer cells can acquire resistance to through alterations of
Top1 functioning (Pommier et al., 2010; Beretta et al., 2013). A protein complex involving
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Top1 mutants and nucleolin bound to G4s could cause increased G4-mutagenesis in cancer
cells as a result of DNA replication blockage and potentially lead to the formation of
secondary cancers in patients treated with Top1-targeting anticancer drugs. In support of
this, while Top1 mutants are correlated with an overall increase in mutations throughout
cancer genomes, Top1 catalytic mutants are associated with increased levels of genomic
aberrations occurring at G4-capable loci in cancers (Figure 33). This indicates that Top1
mutants that are catalytically defective may negatively impact cancer patient prognosis due
to increased G4 DNA stabilization. Moving forward, experiments should be conducted to
investigate if cancer cells treated with CPT have increased levels of G4-induced genomic
instability relative to untreated cells.
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